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SUMMARY: 
The report is composed of four main chapters: 
An introduction concerning the zoosanitary situation in su1-Sahara.Africa, and an estimation 
of the economic impact of improvements in animal health. 
A detailed review of the actors in the livestock sector and the tools available for intervention in 
the contrai of Rinderpest and other major diseases. 
In a third chapter, technical strategies are proposed for the prospective program. This focuses 
on disease surveillance and national systems of epidemiological surveillance with 
support for the laboratories and research (Rinderpest, CBPP). 
Proposals for geographical strategies of Rinderpest and CBPP control adapted to different 
geo-epidemiological contexts make up the last chapter of tb.is report. 
ABSTRACT 
After a brief presentation of the zoosanitary situation in sub-Sahara Afri.ca and an 
economic approach to the positive impact of health improvement on animal production, 
this report puts into perspective the actors and tools concemed with the control of 
Rinderpest and other major diseases in sub-Sahara Afri.ca; the consultants stress in 
particular the important role of P ANV AC, the quality control laboratory for Rinderpest 
and CBPP vaccines used in the vaccination campaigns. The techn.ical strategies 
proposed for the prospective program are based on the concept of disease surveillance 
and national systems of epidemiological surveillance (NSES). 
The consultants introduce the specific objectives, the flow diagram, and the provisional 
budgets of these NSES. It is also proposed that scieniliic support and financial 
haclmig for the national and regional lahoratories is provided as part of the intended 
program, together with reinforcement of the objectives of the regional units, 
hierarchical intermediaries and essential functions. Finally, prioritising the fields of 
research on Rinderpest {use of PPR vaccine instead of the equivalent classic 
Rinderpest vaccine) and CBPP {improvement of current vaccines). 
The final chapter of this report presents the regional geographical strategies for 
control of Rinderpest and CBPP and defines the geo-epidemiological groups in the 
light of the up-dated zoosanitary situations in West, Central and East Afri.ca, the 
livestock farming systems, the role of wildlife, the movements of traditional herds and 
commercial flow. 
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1. 
INTRODUCTION 
First/y, as an introduction to the present summary report, the consultants wish to place the PARC 
program in the context o/ current animal hea/th conditions prevalent in sub-Sahara A/rica and provide 
a comp/ete bib/iographica/ review o/ the economic impact o/ hea/th improvements on animal production. 
1.1. REVIEW OF THE ZOOSANITARY SITUATION IN 
SUE-SAHARA AFRICA 
1.1.1. Rinderpest 
The main resu!t o/ PARC shows that the epidemio/ogical situation o/ Rinderpest has improved overall 
for more than a decade. Tkere have been no Rinderpest outbreak in West and Central A/rica 
since mid-1988. In addition, the reports concerning serosurveillance revea/ no transmission o/ the 
Rinderpest virus in these regions. 
However, East A/rica is still infected, particularly South Sudan, notab/y because o/ the continuing 
civil war which impedes the setting up o/ coherent contra/. Recently the countries to the east of Sudan 
were still in/ected, notably Ethiopia where the last outbreak dates back to November 1995. The strains 
implicated be/ong to /ineage l; these are the strains responsib/e /or the classic type of Rinderpest. The 
situation in Soma/;a remains poorly understood. 
The prominent circulation o/ /ineage 2 strains causes concern; af/ecting the wi/d/;/e in an acute manner 
{Kenya), this alfects cattle in an attenuated /orm .and thus restricts c/;nical detection. 
Wh.ile the development of vigilance networks can replace vaccination in West A/rica, 
Rinderpest remains current in certain regions of East A/rica where vaccination must also 
be accompanied by surveillance measures that include the wildlife. Central A/rica (Chad and 
CAR) constitute an inter/ace between two epidemiological situations and must be the site of 
major prophylactic medical and health measures. However, PARC can be considered, overal/, 
a success. 
1.1.2 Contagious bovine pleuropneumonia 
CBPP is one of the major risks for health and production of cattle in A/rica. CBPP is very 
widespread there and its incidence seems to be recurring in severa/ West A/rican countries. The 
situation however remains poorly understood in several regions, in particular Central A/rica 
because o/ lack of reliable data. ln East A/rica its strong presence menaces southern A/rica: the 
situation in Tanzania threatens to menace Zambia, Malawi and even Mozambique (see map page 81). 
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The bivalent vaccine {Rinderpest / CBPP) seems to have disguised and limited its development in 
numerous countries /or several years. The termination of the use of these vaccines, given the /avourable 
evolution of Rinderpest contro/, cou/d result in a greater d;f/usion of the disease in the A/rican continent. 
The installation of new vaccination campaigns is necessary together with deve/opment of new 
contro/ tools, primari/y more efficient vaccines. An economic approach to prevention is needed 
in the /irst instance in order to determine precise/y the costs and bene/its. The more comp/ex 
epidemio/ogy of this disease compared to Rinderpest consequently demands new 
investigations on the actual role of long term carriers and precise evaluation of animal 
movements. 
1.1.3 Other trans-boundary diseases of major importance 
• Viral diseases
0 Peste des petits ruminants: 
PPR is present in West, Central and East A/rica. It is a disease of major economic importance main/y 
in the rearing of goats. It predisposes animais to secondary infection. With small ruminants being 
susceptible {but not necessarily sensitive) to the Rinderpest virus, the homologous vaccine currently 
constitutes the contro/ method o/ choice: it actual/y allows to serologically di/ferentiate animais vaccinated 
with this vaccine /rom those in contact with the Rinderpest virus (infection or vaccination.) 
0 The pox viruses: 
•:• Lumpy skin disease 
Widespread throughout intertropical A/rica. An economical/y important disease : degradation of skins 
and death in the imported exotic breeds. 
•:• Sheep pox 
Widespread throughout intertropical A/rica. Fatal disease, economically important. 
•:• Came/ pox 
Although present in ail the A/rican countries inhabited by camels, it is a localised benign /orm in adults, 
but causes high mortality in the young. 
0 Foot and mouth disease 
Most/y widespread in tropical A/rica, this disease is too o/ten "tolerated" and considered secondary in 
A/rica. Low mortality in general except in industrial /arming: mi/k production and exotic breeds. 
0 Ri/t Valley /ever 
Declared in Mozambique and Zambia in 1996, suspected in northern Malawi and recent/y in Kenya 
and Somalia (97-98). This is a major zoonoses {Egypt 1978, Mauritania 1988). 
2 
0 A/rican swine /ever 
Appearance o/ the disease /or the /;rst time in th� Ivory Coast in 1996, in Benin, Nigeria and Togo 
in 1997. This is an important factor /;miting pig /arming in A/rica. No vaccine available. 
0 Avian viral diseases: 
The main diseases ri/e in A/rican pou/try are: 
0 Newcastle disease 
0 ln/ectious bursal disease 
0 Fow/ pox 
0 Marek 's disease 
• Bacteria/ diseases
0 Contagious caprine pleuropneumonia 
Mycoplasma capricolum subsp. capripneumoniae agent o/ CCPP has been isolated in the /ollowing 
countries: Niger, Chad, Sudan, Eritrea, Ethiopia, Kenya, Uganda. The economic consequences o/ 
CCPP remain poor/y understood. A vaccine (kilJed, with adjuvant) is availab/e. 
0 Haemorrhagic septicemia 
A relative/y economically import disease that is widespread in intertropical A/rica, becoming ri/e at the 
start of the rainy season. 
The serotype Pasteurella mu/tocida 6 : B present main/y in Ethiopia and north Sudan reached 
Cameroon in 1994. 
0 Bovine tuberculosis 
A disease which is ri/e throughout A/rica, main/y at high altitudes {M.adagascar and the high plateaux 
o/ Eastern and Central A/rica) with a very variable prevalence /rom one country to another: Namibia 
and Zimbabwe are una/fected. Malawi and Tanzania show prevalence rates above 10%. This rate can 
reach 25% in Madagascar. In the latter country, BCG vaccination in the regions of high prevalence 
is considered to be the on/y possible strategy to contrai this disease. 
It is a zoonosis : in Tanzania and Zambia, Mycobacterium bovis, a/though Jess pathogenic to man 
than Mycobacterium tuberculosis, represents a considerab/e risk /or human hea/th. 
0 Dermatophi/osis 
This sign;f;cant disease is ri/e throughout A/rica (most/y humid and sub-humid) and in particular West 
A/rica and Madagascar. It is associated with ticks which represent an aggravation factor. It resu/ts in 
considerab/e economic fosses: morta/;ty and impossibi/ity to practice harnessed traction. No vaccine 
avai/able. 
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0 Bovine and sma// ruminant brucel/osis 
This disease is enzootie in sub-Sahara A/rica with a prevalence that may reach 30% o/ the herd. It is 
the main cause o/ abortion in nomadic herds. It is an important disease /or imported exotic breeds, and 
also in intensive /arming. Brucellosis is a serious zoonosis. 
0 Anthrax 
This is the most serious disease o/ telluric origin and it is ri/e throughout A/rica. It is a major zoonosis. 
0 Anaerobic bacteria/ diseases 
These diseases are present in the whole o/ sub-Sahara A/rica. Black leg may be enzootie (Comores). 
Tetanus, botulism and gas gangrene play a considerable role. 
• T rypanosomiasis
Currently animal trypanosomiasis represents, wUhout doubt, the main constraint on /arming in humid 
tropical, sub-humid and arid (camels) A/rica. Around 30% o/ cattle living in the tsetse zone are exposed 
to the disease. 
• Principal tick-borne diseases
They represent a major constraint /or the increase in productivity o/ cattle in humid and sub-humid 
A/rica. 
The main diseases are: 
<> babesiosis 
<> theileriosis: essentially East Coast Fever (Theileria parva) in east and 
southern A/rica. 
<> anaplasmosis 
<> cowdriosis which has some economic impact. This disease is o/ten underestimated 
(numerous cases are unnoticed). 
NB: dermatophi/osis is also a disease associated with ticks. 
• Helminthiasis
This represents a major constraint in A/rica, particularly /or intensive /arming. 
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1.1.4 Diseases o/ secondary importance encountered in sub-Sahara A/riaa 
Sorne diseases have been identified. Their economic impact is not considered to be a determining factor. 
One can quote: 
•:• Bovine viral diarrhoea (BVD), mucosal disease (MD) 
•:• In/ectious bovine rhinotraaheitis (IER) 
•:• Bovine leucosis 
•:• Caprine arthritis/encephalitis : CAEV {Nigeria, Burundi) 
•:• Bovine Jarcy 
•:• Melioidosis 
•:• Leptospirosis 
1.1.5 Hierarchy o/ health constraints by country 
• In general one can propose by order o/ decreasing priority:
•:• Rinderpest, Peste des Petits Ruminants, CBPP 
•:• Trypanosomiasis 
•:• CCPP, /oot and mouth disease, poxviruses 
•:• Abortions {bruaellosis, Rift Valley /ever) 
• The study o/ respiratory diseases in ruminants constitutes a major theme /or epidemiological
monitoring in itsel/ (abattoirs, areas o/ slaughter).
• The proposed order of priority wou/d be adapted depending on the zoosanitary
characteristics of each country and the skiffs of the national faboratories.
1.2 ANIMAL HEALTHAND ECONOMY 
1.2.1 Economie consequences of animal diseases 
De Haan and Bekure (1991) estimate that the direct costs due to mortality of herds in sub-Sahara 
A/rica reach about 2 billion US $ per year and that the indirect costs (/owering of development rate, 
/ertility and work /or draught animais) represent the same amount. This total annual loss o/ 4 billion 
US $ per year is equivalent to 24% of the animal production in sub-Sahara A/riaa. 
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1.2.2 Estimation o/ the economic impact o/ improvements in animal health 
Severa/ economic studies are presented whose aims are as /ollows: 
• To evaluate the interest o/ the creation o/ vaccination programs. eg. Rinderpest, CBPP,
brucellosis.
• To determine the economic impact o/ health improvements on animal production. eg.
trypanosomiasis.
• To specijy the importance o/ international programs o/ epidemio/ogical surveillance. eg. classic
swine /ever; A/rican swine /ever.
1.2.3 Rinderpest 
• ln his doctoral thesis entit/ed "The contrai of Rinderpest in Côte d'Ivoire - costs and benefits
o/ preventive campaigns. Problems posed by its eradication" (1994), Emmanuel Couacy­
Hymann proposed an economic evaluation of preventative campaigns against Rinderpest. His
approach is as /ollows: "the zoo-technical parameters o/ /arming systems and the e/fects o/ the
disease on these can give a mode/ of animal production that determines the productivity of the
herd in the presence or absence o/ the disease. The economic lasses due to Rinderpest result in
di/ferences in production between the hypothesis "with " and "without" vaccination, calculated
with the he/p o/ a computer simulation mode/ of the changes in the herd {Livmodll).
• The zoo-technical parameters are taken /rom a samp/e o/ 139,000 cattle in the north o/ Côte
d'Ivoire.
• The /ollowing hypotheses have been sttfdied
0 Hypothesis A : with vaccination project 
•:• AO : * Presence o/ Rinderpest in enzootie zone despite vaccination 
* Epizootie /or 2 years a/fecting animais of 0-1 years and 1-2 years
* Mortality rate : 4% 1st year 
2%2nd year 
•:• Al Ditto with mortality rate higher : 10% 1st year 
5%2nd year 
0 Hypothesis B : without vaccination project 
•:• Bl or lziglz lzypothesis: mortality rate 40% 1st year 
20%2nd year 
•:• B2 or low hypothesis: mortality rate 20% 1st year 
10%2nd year 
0 ln both hypotheses, A and B, the epizootic recurs every 5 years; which is the time 
necessary in order to reach a critica/ thresho/d of sensitive animais and /or the herd to 
reconstite itse/f 
0 The projection is on a duration of 12 years with 2 epizootic waves {between years 
5-6 and years 12-13).
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0 The costs and lasses based on these hypotheses allow the cost/benef;t ratio of 
vaccination campaigns to be determined. 
0 The evaluation criteria are: 
•:• The real net value (RNV) that is obtained by deducting the real value of costs (RVC) 
/rom the real value of bene/;ts (RVB). This provides a precise notion of the total 
advantage resulting /rom a project. 
•:• The internai rate of return aRR) currently used to compare projects. 
0 Mode//ing costs and benef;ts of a Rinderpest vaccination project 
Simulations give the /ollowing results: 
The cost per animal vaccinated during a PARC project in Côte d'Ivoire varied /rom 101 
FCFA in 1989 and 72 FCFA in 1991 (1 FCFA = 0.02 FF be/ore devaluation in 
1994). 
The interna/ rate of return osci//ated between 31.7% (10% hypothetical mortality) and 
88% (40% hypothetical mortality), according to the mortality rate applied /or the simulation 
in the two hypotheses A and B over a period of 12 years with an initial herd of 1 mi/lion 
cattle. 
The pro/;t created by the vaccination project varies according to the hypothesis /rom 518 
mi/lion FCFA {hypothetical mortality rate o/ 10%) to 4883 mi/lion FCFA {hypothetical 
mortality rate of 40%). These resufts fui/y justify the vaccination programs against 
Rinderpest. 
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Calculation o/ evaluation criteria (RNV and JRR) o/ preventative campaigns against Rinderpest: 12 
year projection /or a herd o/ 1 million cattle; current value conversion rate: 10% (x 1000 FCFA) x 
(1000 cattle) 
Mortality rate Mortality rate Without project With project NPV Profit(*) IRR 
(A.P.) (W.P.) RNV (p. 100 ) 
10 p. 100 62 573,40 63 091,30 518 
4 p. 100 
20 p. 100 61 063,60 63 091,30 2 027,80 
40 p. 100 58 207,90 63 091,30 4 883,40 
20 p.100 61 063,60 62 312,90 1 249,40 
10 p. 100 
40 p. 100 58 207,90 62 312,90 4 105 
(*)The calculated profit does not take into account the residual value o/ investments and the growth o/ 
the herd. In /act the LIVMOD software is on/y based on the sales o/ animais (in our case) to calculated 
to desired economic parameters. 
RNV: rea/ net value 
NPV: net present value 
IRR: internai rate o/ return 
A.P. : with vaccination project 
W P. : without vaccination project 
•:• Other examples : 
0 Nigeria 1980 - 1984
B. Couacy-Hymann, 1994. University thesis.
Rinderpest decimated 382,000 catt/e and provoked emergency vaccination o/ more than 10 
million cattle. The total Joss was estimated at 2 billion US $; the specif;c costs of contro/ 
of epizootics in Nigeria on/y represents 6.4% of the total (128 million US$) (According 
to Nawathe et al. 1984). 
0 Yemen Republic 
The estimated profit resulting /rom vaccination against Rinderpest is 5.4 million US $ per 
year. This represents about 20% of imported animais each year (A. James, 1991). 
0 Ethiopia 
Tambi and Coll (1998) studied the economic losses due to Rinderpest and the profits 
engendered by its contro/ concluded: 
The total annua/ economic Joss due to Rinderpest in Ethiopia is 9.3 million US $ and 4 
US $ per animal. 
Thus it is clearly demonstrated that the PARC campaigns in Ethiopia with a cost o/ 0.24 US 
$ per animal are economically profitable and contribute sign;f;cant/y to the increase in the 







1.2.4 Contagious bovine p/europneumonia 
• JN. Nwanta and J U. Umoh (1992) studied the epidemiology of CBPP in the northern states
of Nigeria (1992) and showed that over a period of 20 years there was a close negative
correlation between the number of vaccinations and the number of outbreaks declared.
The results showed clearly that when the vaccination campaigns were intens;j;ed between 1975 and 






















CEPPO tb k d ·t t' u rea s an campa1gn s1 ua 10n m N t · 19701989 1gena -
No. of No. of animais in Total death Mortality (%) 
outbreaks the a/fected herds record in the 
a/fected herds 
38 3 385 534 15.8 
89 4 830 700 14.5 
111 14 718 3000 20.4 
47 14 139 2237 15.8 
71 8 434 725 8.6 
35 5 392 303 5.6 
35 3 868 - -
15 - - -
23 7 260 608 9.8 
15 1 570 177 11.2 
28 2 612 309 11.8 
11 1 454 77 5.3 
36 4 735 415 8.7 
13 1 025 133 13.0 
28 1 875 204 10.9 
25 2 386 255 10.7 
46 6 293 343 5.5 
49 5 133 559 10.9 
64 5 584 531 9.5 




1 448 288 
2 602 212 
2 500 672 
3 014 601 
2 911 246 
3 485 013 
2 200 000 
4 542 566 
5 246 988 
6 236 888 
5 900 000 
6 083 475 
4 065 710 
3 642 122 
4 916 682 
6 897 793 
4 980 474 
3 747 587 
2 986 825 
Source : National Rinderpest / CBPP contrai programme. Annual Report on Field Activities 
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Nwanta J.N., UMOH J. U. .. Epidemiology o/ Contagious bovine pleuropneumonia (CBPP) m 
Northern states of Nigeria: an update. Rev. D'Elev. Med. Vet. Pays Trop. 1992 - 45(1): 17-20. 
a S.B. Oluokun (1980), studying the cost/benepts of CBPP control programs in Nigeria 
showed: 
•!• The total loss due to CBPP in Nigeria in the absence of contra/ programs /or the 
disease is 500 million Naira. 
•!• The total Joss due to CBPP with.in an eradication /contrai program such as JP28 
is 200 million Naira: 
•!• The total profit due to tactical eradication /controf is there/ore around 300 m_il/ion 
Naira. 
•!• The total cost of campaigns of continuing or proposed eradication / controf being 
about 20 million Naira, the cost/benef;t ratio of such a campaign is around 
15/1, which Jully justi/ies the creation o/ these programs o/ heafth improvement. 
1.2.5 Bovine brucel/osis 
J. Domenech et al. (1982), studying the economic impact o/ bovine brucellosis in central A/rica (Chad,
Cameroon) as well as the costs and benepts o/ improvement operations, clearfy demonstrated that:
• Bovine brucelfosis in the region where the infection rate is 30% o/ reproductive /emales (thus 
about 20% o/ the total herd) causes economic fosses of about 5.8% o/ the gross revenue
per anima/.
• The use o/ a computer simulation mode/ has permitted the calculation o/ costs and benepts o/
improvement operations in the zones with infection rates o/ 30 and 40%.
ln both cases, improvements due to vaccination represent a def;nite economic interest,
by extrapolating to the impact on public hea/th, particularly in the zones where the
infection rate is very high (40%).
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1.2.6 Animal trypanosomiasis 
Tsetse f/ies /imit or prevent animal production in humid tropical A/rica over an area of nearly 
7 million km2 which wou/d otherwise provide important potentia/ grazing. The experts estimate that 
33 million extra cattle could be /armed. 
FAO indicates that 60 million catt/e and 100 mi//;on small ruminants are currently exposed to 
the disease. 
• Wh.at are the direct e/fects of trypanosomiasis on sensitive cattle ?
•!• Reduction o/ birth rate by 10 to 20% .
•!• lncrease in mortality rate o/ calves by 10 to 20% 
•!• Reduction in milk production o/ 10 to 40% 
•!• Reduction in meat production o/ 5 to 30% 
•!• Reduction in work by harnessed cattle 4 30% 
•!• Reduction in production o/ small ruminants by 5 to 38% 
ln genera/, trypanosomiasis reduces the cattle density by 37% in sub-humid zones and by 70% in 
humid zones, and the total agricultural production is reduced by 2 to 10% in these same zones (B. 
Swallow, PAAT Maputo, 1997). 
ln the mixed agricu!ture/stock-breeding systems, the areas o/ cultivation or /arming can be reduced by 
50%. 
The sub-humid zones provide an important potential to cope with projected meat def;cits in sub-Sahara 
A/rica, subject to contrai of trypanosomosis. According to the World Bank calculations, animal 
production must increase in the next 30 years by around 4% per year to caver the A/rican demand 
(1.1 % per year for bovine meat}. Msel!ati and Tacher (1991) comparing zones una/fected by tsetse 
//;es and treated zones estimated that eradication of tsetse f/ies cou/d increase meat production 
by 16% and mi/k production by 18% for ruminants in sub-Sakara A/rica. 
1.2.7 Classic swine /ever 
• Based on cost/benef;t analysis, James and Ellis (1979) evaluated the impact o/ vaccination in
f;nancial and statistical terms:
•!• The expected net profit /rom vaccination is about 4 ECU/ pig 
•!• The probability o/ non-vaccinated pigs becoming in/ected is 0.17 whi/e the same 
probabi/ity /or vaccinated animais is on/y 0.0085. 
• Ellis et al. (1977) used this same method in order to propose a standard contro/ strategy
against classic swine /ever applicable to the whole o/ the European Union. Tke absence of 
common healtk po/icies /imits commercial f/ow.
Il 
• They compared four possible strategies:
A - Bach Buropean country continues to app/y its own strategy 
B - Indef;nite mass vaccination 
C - Cessation of vaccination; serological surveillance and elimination of positive animais 
D - Same as C but more intensive 
• They clearly concluded that in terms of costs and beneftts the best strategy is C: a hait in
vaccination, serologica/ surveillance and e/imination of positive animais.
• Over 10 years, with respect to strategy B:
A - costs 4 times Jess 
D- costs 4.8 times Jess
C - costs 6.15 times Jess 
1.2.8 A/rican swine /ever 
• This disease was declared in the Côte d'Ivoire in 1996, resulting in the death of 40,000 pigs
and the emergency slaughter of 80,000 animais resulting in a total Joss of 120,000 head
between May and Ju/y 1996.
The /armers received compensation of 1.8 billion FCFA (2,7 mi/lion ECU) /rom the Côte
d'Ivoire state.
The total economic cost is estimated at 10 billion FCFA per year (15 mi/lion ECU).
• Following this epidemic, FAO set up a TCP /or the implementation of an emergency network
o/ regional epidemiological surveillance in eight countries {Benin, Burkina-Faso, Côte d'Ivoire,
Ghana, Guinea, Liberia, Mali and Togo). The proposed budget /or this TCP FAO is 286,000
US$ or 268,000 ECU.
The interest of such a preventative strategy is evident in the /ight of payment of 2.7
mi/lion ECU in 1996 by the Côte d'Ivoire government to compensate the /armers who were




ACTORS AND TOOLS 
First of ail the actors and tools available for intervention in support of the fu,ture contrai 
program for Rinderpest and the other dominant diseases in sub-Sahara A/rica should be 
placed brief/y in perspective. During the course of the present summary, their roles wi/1 be 
amp/;fied in detail. 
2.1 THEACTORS 
2.1.1 The /armers 
In terms o/ Rinderpest contro/, the /armer wi// /ind himsel/ in two situations: 
- to be associated with vaccination of his herd
- to be at the heart o/ a surveillance network
For this second point in particular, it is important to motivate the /armers and to provide them with 
$pecific information to encourage them to declare a pestivirus /ike disease. 
2.1.2 Farmers associations 
They /avour the establishment o/ surveillance networks and participate active/y in Animal Health 
Associations (AJIA). 
2.1.3 Animal Health workers 
Their role and allocation can vary depending on the national and local (ethnie) context. A sociological 
approach may be necessary: the power con/erred by the possession o/ medicines and their usage can 
damage the traditiona/ power within a given ethnie group. At their leve/, the auxiliaries wi// play an 
essentia/ role as part of epidemio/ogica/ vigilance (training). 
2.1.4 The veterinary services 
Faced with the deve/opment o/ the /ree sector, the State veterinary services have lost importance. 
They have an essentia/ ro/e to play in matters o/ contro/ of epizootics. This inc/udes an organisationa/ 
{/armers' co-operatives, /or example), institutional and, in particular, statutory (sanitary mandate, 
veterinary association) viewpoint, in addition to public hygiene. The fu,ture PARC program 
must be an integral part of the national veterinary services. It wi// be the "pivot" o/ the animal 
health department of veterinary services in a country. 
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2.1.5 The liberal veterinary sedor 
The involvement of private veterinarians in the control o/ Rinderpest is dependent on the existence o/ a 
sanitary mandate involving rights and duties in relation to the State. This mandate must inc/ude 
the other major diseases. 
The situation in the /ibera/ sector is very variable depending on the country and should be harmonised. 
Sorne countries have not yet created veterinary associations, nor have they set up sanitary 
mandates. 
Moreover, this idea o/ sanitary mandate is o/ten badly integrated by the agents in veterinary practice. 
As part of the future program, problems such as the method o/ payment for private veterinarians, 
the means /or aid and fiscal help for installation, along with /urther education o/ independent 
practitioners under the auspices of the sanitary mandate will be considered. 
2.1. 6 Abattoirs and slaughter areas 
Renovation o/ some of these structures must be envisaged. Surveillance at the leve/ o/ abattoirs provides 
important information /or the determination of the prevalence of CBPP in a country and the screening 
of possible attenuated /orms of Rinderpest. 
2.1.7 National laboratories /or veterinary analysis 
The relations P ARC/Laboratory should be redef;ned and harmonised. The status o/ these 
laboratories with respect to PARC co-ordination is ofien il/ def;ned and d;f/ers between countries. The 
future program must provide direct f;nancial and technical support to these laboratories in the f;elds 
which concern them (serology and microbiology) notably /or specijic laboratory equipment, consumables 
and working budgets. 
2.1.8 Technical assistance 
The maintenance of a technical assistance in the cordon(s) as wel/ as in recently infected or in/ected 
countries is necessary. 
2.1. 9 Regional units 
In the proposed strategies, the role of current co-ordinators {Bamako, Nairobi} should be rein/orced in 
the f;eld o/ epidemiological surveillance and extended to other spheres in the /ol/owing sectors: 
•:• Laboratories 
•:• Animal Health Associations 
•:• Quality control o/ vaccines used in the f;eld 
2.1.10 Re/erence laboratories 
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The regional and world re/erence laboratories have a primordial role o/ scienti/ic support and network co­
ordination of the regional and national laboratories. 
2.1.11 International organisations 
They intervene through OAU/JBAR {European Union) each one in their /ield of competence. ln the 
future program, the institutional and technical co-ordination between OIE, FAO, IAEA, PANVAC 
and the reference laboratories on one hand and OAU/IBAR. on the other must be reinforced. 
2.2 THE TOOLS 
2.2.1 Vaccines 
• Rinderpest
It is currently recommended that the use of the thermostable vaccine be standardised taking into 
account the /o/lowing constraints: 
•:• The techno/ogy trans/er to producing /aboratories involves good quality industrial 
equipment, maintenance and training. 
•:• The relative thermostability involves information /or the users. 
The proposed end to the use of Rinderpest vaccine in ruminants leads to a change towards use of 
vaccine for peste des petits ruminants. This wi/l allow the d;f/erentiation of in/ected and vaccinated 
animais. This outlook is more Jully explained in the chapter "Lines o/ research ". 
• Contagious bovine pleuropneumonia
The weak immunity conferred by the current vaccine leads to the development of several lines of 
research aiming to ameliorate the thermostability, the duration of immunity and the sa/ety of vaccines. 
These projects are presented in the chapter "Lines of research ". 
• It is evident that the external thus independent context of the control carried out by the P ANV AC
laboratory {Ethiopia) must be maintained and rein/orced. This important point is developed in 
the chapter "Technical strategies ". 
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2.2.2 Epidemiological methodo/ogy 
• It seems necessary to rein/orce the capacities of national constituents in the f;e/d of samp/ing
(serological monitoring, serologica/ surveillance .. ), data analysis and exploitation of resu/ts. 
• The use of geographic information systems (GIS) app/ied to the contro/ of in/ectious diseases
is recommended.
This is involved in terms of the spatial representation of d;f/erent data (cartography): movements
and density of herds {including the wi/d/;fe : contact zones between domestic and wild ruminants),
vaccination coverage ...
The development of GIS sensu stricto could be the object of a spec;fic research program in the /uture
and cou/d result in a he/pju/ tool /or use in decision making. ln the /ramework of emergency
intervention plans, a geographical information system cou/d also allow the rationalisation of
interventions in the management of an outbreak taking into account its locality, the bulfer zone, the
distances between the outbreak and the veterinary services, the number of animais the road access,
etc ...
2.2.3 The legislative apparatus 
The legislative texts must be def;ned within the /rame of national directions of veterinary services in 
close co-operation with the /uture program. They concern: 
•:• Passports / international certiftcates of vaccination in the sanitary cordons 
•:• The Animal Health Associations (A.HA) 
•:• Legally contagious" diseases 
•:• Surveillance measures 
•:• The emergency preparedness plannings 
•:• The sanitary mandate 
•:• The veterinary associations 
This indispensable regulatory context should allow the state veterinary services to reposition themselves 
with respect to the /arming agents. 
2.2.4 Standard methods of laboratory analysis 
OIE and AIEA/FAO have validated a certain number of standard methods with the assistance of 
world reference laboratories (a-ELISA and Rinderpest immunocapture, CFT /or CBPP). Others are 
in the process o/ validation {a-ELISA CBPP). 
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2.2.5 Communication 
This section must be rein/orced with respect to the epidemiological surveillance network. Its ro/e is 
essentia/ to insure the setting up and assessment of sanitary cordons and the /armers' information 
/or the declaration o/ Rinderpest-like-diseases. 
2.2.6 Training 
This concerns ail the actors of the epidemiological surveillance network. This section is Jully 
exp/ained in the present report. 
3. 
TECHNICAL STRATEGIES 
This chapter explains in detail the technical strategies permitting the member countries of the proposed 
program to undertake control of Rinderpest within the procedures of OIE. It also considers 
progressive/y the other major zoosanitary constraints within the integrated strategies whose "pivot" is 
rftpresented by the "national system of epidemiological si1:rveil/ance ".
3.1 EPIDEMIOLOGICAL SURVEILLANCE AND THE 
NATIONAL SYSTEM OF EPIDEMIOLOGICAL 
SURVEILLANCE (NSES) 
3.1.1 Generalities 
• Epidemiological surveillance is a method based on continued recording that allows the state o/
hea/th or the risk factors of a def;ned population to be assessed. In particular it slows down the 
appearance o/ pathological processes and permits studies o/ the development over time and space 
o/ the adoption o/ appropriate measures of contro/ (Glossary of epidemiology, Toma, B. et al, 
1991). 
• Epidemiological vigilance is just a /orm of epidemiological surveillance aiming to locate the
introduction of disease absent in the country. 
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• Epidemio/ogica/ surveillance is characterised by:
•:• simp/if;ed procedures of data collection 
•:• representative samp/ing of /arming or villages under study 
•:• rapid circulation of reliab/e information /rom the decision makers and the field agents 
• Al/ the available human and technical means within a country, whose aim is to collect analyse and
retransmit information, constitute the national system of epidemio/ogica/ surveillance 
(NSES). lts aim is to provide the decision-makers with reliable information in time /imits 
compatible with decision making. The services in charge can prioritise the diseases, establish 
strategies, determine actions to undertake and evaluate the impact o/ actions based on this 
information. 
For a NSES to be able to carry out its role, at least two conditions must be /u/f;lled: 
•:• the durabi/ity of the system put in place 
+ the co-operation of the maximum number of agents
• Reminder of def;nitions
0 Serologica/ monitoring: 
This is the research by serological methods /or the presence o/ antibodies in vaccinated animais. ln 
reality, it is the search for negative animais in a population previous/y considered positive. 
0 Serological surveillance: 
This is the research by serologica/ methods /or the presence o/ antibodies in non-vaccinated animais. It 
is an active search for positive animais in a population previous/y considered negative. It is one o/ 
the methods used to conftrm that the Rinderpest virus is not circulating. 
3.1.2 Spec;fic objectives o/ a NSES: 
• ln a country, the current Rinderpest network represents the ftrst component o/ the system.
Within this /ramework, the aim is to extend the epidemio/ogica/ surveillance to other 
diseases, taking into consideration the dominant pathologies by country (CBPP in the ftrst 
place, of course.) 
• The future sera collections for Rinderpest constitute a precious sampling basis /or the approach
to other diseases. 
• Very schematically, the objectives o/ a NSES are o/ two orders:
0 ln the ftrst place, ensuring active surveillance of Rinderpest. This inc/udes: 
•:• For in/ected countries : 
- Active research /or residua/ outbreaks (clinics and laboratory support)
- The study o/ methods o/ progression o/ the disease
- The setting up of contrai strategies (vaccination, serological monitoring ... )
•:• For the sanitary cordons:
Contrai strategies: Cf above.
•:• For una/fected countries:
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- Sero/ogical surveillance, clinical surveillance and active searching /or the virus according ta the
OIE pathway (1993). 
•!• An early warning system and emergency preparedness /or ail the countries. 
0 Bnsuring passive and active epidemiological surveillance of the territory: taking into account 
the main health constraints o/ each country {Rinderpest, PPR, CBPP . .) 
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• ln order ta /urther harmonize the di/ferent groups on an epidemiological point of view, it might be necessary ta 
include the Southern aeras of Nigeria and Cameroon in group 1. ** T1ze outbreaks in Sudan have been located in the 
Eastern part of the country {Right bank a/ the Ni/e) whereas the Western part seems una/ected. 
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3.1.4 Proposed general scheme /or a NSES 
• Considering the identified objectives (Cf paragraph 3.1.2) and the geographic situation o/
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• T1ze parlners of NSES are essentially:
Passive & active 
ép idemiological 
surveillance ofthe 
dominant pathologies per 
country: Rinderpest, PPR, 
CBPP, trypano .... 
Provincial Units 
State field agents 
• observation posts 
• mobile teams along the 
border& 
•!• The veterinary services direction (VSD) in charge o/ the system 
•!• The national co-ordinator o/ the PARC project 
•!• The veterinary board council and the pro/essional associations 
•!• The national veterinary laboratory 
•!• The agents o/ public and parapublic organisations involved in /arming 
•!• The private veterinarians 
•!• The slaughter houses 
•!• The /armers, /armers associations and Animal Health Associations 
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• Comments
0 One o/ the major concerns o/ the proposed program is to be able to provide institutional 
support to the member countries by the creation of durable NSES associating ail the 
agents and whose /irst vocation resides in epidemiological surveillance of Rinderpest 
in the countries where it no longer exists. 
On the other hand, the control of this disease, as well as active surveillance, 
remains an absolute priority in the infected countries or those with a high or very 
high risk. 
0 Considering the specijic zoosanitary situation with regard to Rinderpest and other major 
diseases, each member country of the proposed program could decide, within the /ramework 
of its NSBS to broach other themes such as CBPP, by de/ining the parlicular 
prolocols of control and epidemiological surveillance adapted to each disease considered by 
theNSES. 
0 ln this perspective, the logistic and /ir]ancial advantage of a NSBS resides in the fact that 
the "basic" agents are in general the same for the d;fferent "themes". 
On the other hand, while a country would have been recognised as unaffected by Rinderpest 
according to the O JE, its NSBS will continue to "take charge" of other dominant diseases. 
0 71zus, the creation of the NSBS will permit installation of durable and polyvalent 
systems without the creation of heavy and cost/y structures. 
0 71ze constitution o/ a NSBS implies the re-positioning of national veterinary services 
that are o/ten unmotivated and unstructured faced with the growth of the /iberal sector 
as well as the reinforcement of their missions. 
0 Final/y, the NSBS must favour the creation o/ a consultation forum of the different 
agents; this aspect is currently very much at fau/t in the national constituents visited 
by the consultants. 
3.1.5 Description and calculation o/ costs of dif/erent constituents o/ a NSBS 
• Pilot committee
0 Chaired by the director o/ veterinary services, it is the organ of decision that de/ines the
po/icies to be carried out. 
0 It determines the working themes, supervises the central epidemiological unit, governs the 
different possibi/ities between the agents, and controls the edition and di/fusion of a 
periodical information bulletin. 
0 No specijic costs identijied at this level. 
• Central epidemiological unit
0 It is the kingpin of the NSBS
0 It regroups the national skil/s available in epidemiology, diagnosis, statistics, computing,
communication ...
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0 The assignments are : 
•!• At the start, at the request of the pilot committee to set up di/ferent levels of 
NSES , to specify the objectives, to redirect the internai regulations. 
•!• To establish on the other hand the samp/ing bases, to standardise the collection 
procedures as well as their periodicity, to determine the supports and methods of 
information diffusion. 
•!• To organise the network: training of interviewers, centralisation, analysis and 
diffusion of information 
•!• To set up crisis units for Rinderpest (emergency preparedness) 
0 Estimation of costs /or the central epidemio/ogical unit 
•!• The two main organisations involved are 
- the Director of veterinary services
- the national veterinary laboratory
•!• Two 4x4 vehicles: 25,000 ECU x 2 . . . . . . . . . . . . . . .  50,000 ECU 
•!• Computer equipment, sampling materia/, 
treatment of samples, autopsy instruments . . . . . . . . . . . 15000 ECU 
•!• Photocopier . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5000 ECU 
•!• Communication 
•!• 1 /ax/te/ephone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1500 ECU 
•!• Edition: information bulletins, posters, notices 
questionnaires . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15000 ECU 
•!• Field trips: 
Two people 60 days x 2 
50ECU x60 x2 . . . . . . . . . . . . . . . . . . . . . . . . . . . .  6000 ECU 
•!• Responsibi/ity allowance: 25% monthly salary 
•!• Assignment expenses /or intervention in the field are also planned /or the mobile 
units, the provincial units and the field agents (C/. § 5.3, 5.4, 5.5) 
0 GIS and infectious disease: Rinderpest and CBPP 
The installation of mapping systems and geographic information necessitates having reliab/e field data 
available. These data wilJ corne /rom NSES /or financia/ reasons. 
GIS and animal movements 
Aims: 
•!• lmprove definition of risk zones /or Rinderpest and CBPP 
•!• Identi/y the contro/ zones (cordon) 
•!• Identi/y the meeting zones (vaccination) 
lmplementation by: 
•!• Use of existing but dispersed data (e.g. Chad) 
•!• Acquisition of data: NSES (and /requent surveys); geo-re/erence of departure 
and arrivai points. 
To represent not on/y the movements but also the quantitative aspects. 
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Costs o/ so/tware: 
Mapin/o Pro/essional 4.5: . . . . . . . . . . . . . . . . . . . . . . . . 2000 ECU (be/ore tax) 
Outil Fluxour (cartes de /lux et d'oursins: 
representation of exchanges, importance o/ movements, 
realisation o/ centres o/ attraction, etc . . . . . . . . . . . . . . . . . . . . . . 460 ECU (be/ore tax) 
GPS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800 ECU {be/ore tax) 
Support mission 
To be imp/emented at the leve/ o/ co-ordination in Abéché /or the sanitary cordon and the regiona/ co­
ordination. 
GIS and the Emergency Plan 
Use o/ a GIS integrating the previous data (movement) and /ogistic data; management o/ outbreaks 
ie. taking into account the /o/lowing data: localisation o/ outbreaks, bu/fer zone, distance between 
outbreak and veterinary services, number of animais, road access etc .. 
Management by the co-ordination and development in the NSES (integrating within the epidemiological 
units). 
• Mobile units: Rinderpest
0 OIE Pathway 
•:• The objectives are: 
- serological surveillance
- clinical surveillance
-active search /or the virus
- rapid intervention
0 Standard sampling methods /or epidemiological surveillance o/ Rinderpest 
(OIE, 1993): 
•:• Serologica/ surveillance: 
The basic princip/e of sampling is as /o/lows: 
300 herds /stratum/or 3 years 
The number o/ b/ood samples wil/ be /rom 10 to 57 per herd of 10 to 100 animais. This 
corresponds to the sample size necessary to obtain a probability o/ 95% detection o/ a disease 
whose prevalence is 5% among animais non-vaccinated /or more than 1 year. 
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•!• Clinical surveillance 
Same principle: 300 herds / stratum /or 3 years. 
Corresponds to the samp/e size necessary to obtain a probabi/ity o/ 95% detection o/ a disease 
whose prevalence is 1 %. A stock can be composed o/ 10 to 1000 animais /or examp/e. 
•!• Rapid emergency preparendness 
- ln case a suspected case of Rinderpest is conprmed, an emergency intervention plan must be
availab/e and thus previous/y defined.
- The e/ficacy o/ the plan cou/d be tested using simulations based on an ident;fied source o/ CBPP
or foot and mouth disease, /or examp/e, and thus lead to an analysis o/ the critica/ points in order
to rein/orce the capacities.
- Basic /ogistics must constant/y be provided:
. A stock of Rinderpest vaccine is avai/ab/e 
. A permanent veterinary cash advance /or rapid intervention 
. Field intervention: one specipc 4x4 vehicle and an ident;fied mobile team (veterinary 
services + laboratory) ready to intervene . 
. A national operational laboratory (Cf chapter "PARC support to laboratories'� 
0 Outside of the OIE Pathway: 
Mobile units planned /or una/fected areas, bu/fer zones, cordon sanitaires and in/ected areas in 
particular /or vaccination, serologica/ monitoring and surveillance. 
0 Number of strata per country 
•!• The strata allow the population to be subdivided into groups exposed to the same risks of 
persistence of Rinderpest. 
•!• The risks depend on 
* the geographic region
* the production system
•!• Within the OIE pathway one can consider 1 to 3 maximum strata per country 
•!• Outside the OIE pathway : /or harmonisation one can also retain the idea of 
strata /or a buffer zone, a sanitary cordon and an in/ected zone. 
0 ln principle, one mobile unit per stratum, except /or the main sanitary cordon /or which are 
proposed two mobile units /or each o/ three countries concerned (Chad, CAR, south Sudan) 
being six mobile units in total in this cordon. 
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D Estimation of costs /or a mobile unit: 
•!• 1 4x4 vehicle per unit . .............................. 25,000 ECU 
•!• Autopsy kit+ material ............................... 2,000 ECU 
•!• Diverse field equipment (conservation) . . . . . . . . . . . . . . . . . . . . . 5,000 ECU 




•!• staff expenses: 
- per diems /or field trips. . . . . . . . . . . . . . . . . . . . . . . . 10,000 ECU/year 
- incentive allowance: 25% o/ month/y salary
•!• Running costs (petrol, vehicle maintenance 
consumables) ............................ 10,000ECU / year 
• Provincial units
D Considered as indispensable relays between the central epidemiological unit and the field
agents to ensure good co-ordination of the NSBS, the d;f/usion o/ information and 
training. 
D J provincial unit /or 10 field observation posts. 
D Estimation of costs /or a provincial unit : 
•!• 1 4x4 vehicle per unit . ......................... 25,000 ECU 
•!• 1 cold chain (acquired in generaV 
•!• The team is composed of : 
- 1 state veterinarian
- 1 driver
•!• Per diems /or field mission: . . . . . . . . . . . . . . . . . . . . 3,000 ECU/year 
•!• Running costs (petro/, vehicle maintenance, 
telephone, electricity) ........................ 5,000 ECU /year 
•!• lncentive allowance: 25% of month/y salary 
• State field agents
D The tasks of these agents are as /ollows:
•!• Observation posts: 
*
* 
Active epidemiological surveillance of the territory /or Rinderpest and the
other major health constraints ident;fied per country (clinical assessments, 
questionnaires, surveillance of markets, abattoirs .. ) 
The role of questionnaires is important to provide information on the actual 
situation of Rinderpest in a given zone, /or example in order to try to prevent 
the possible extension of the disease. They provide use/ul information on herd 
movements (nomads, commercial f/ow, markets .. ). Bthiopia uses very complete 
spec;fic questionnaires /or the nomadic zones and the highlands. They must be 




considered a good approach to /acilitate and rein/orce the relations on the 
f;eld between the veterinarians, the technicians and the stockbreeders 
and to maintain a state of alert. 
Contro/ of vaccination certïficates and international pas sports. 
For Rinderpest in parlicular: early warning system, 
Reminder: one provincial unit /or 10 observation posts. 
•:• Mobile teams along borders: 
* Known as "Goumiers" in the Central A/rican Republic
* Their role is -to collect information /rom the borders (herd movements, vaccinated and
non-vaccinated animais, disease identïfication) 
* No direct contro/ role
0 Estimation of costs /or these agents: 
•:• Observation post: 
* one post over 5 years
* one state agent: 12 months salary: . . . . . . . . . . . . . . . . . . . . 2,000 ECU/year 
* one incentive allowance: 25% of month/y salary .............. 500 ECU/year 
* one motorbike per agent: renewable a/ter 3 years
3600 BCU/3 years = . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,200 ECU/year 
* autopsy kit (renewed once) . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 ECU /year 
* ice box + ice packs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200 ECU/year 
* NB: renewa/: 1/2 re/rigerator / 5 years
* running costs + motorbike maintenance . . . . . . . . . . . . . . . . 1,000 ECU/year 
TOTAL: ................................... 5,000 ECU/year 
* The number of observation posts necessary per country will be depned by the OAU-IBAR
taking into account the number of heads of catt/e (bovine, sma// ruminants) / territory sur/ace.
•:• Mobile teams along the borders: 
* "G · " b d t one oum1er per o� er pos s
* salary: 125 BCU/month x 12 = . . . . . . . . . . . . . . . . . . . 1,500 ECU/year 
* incentive allowance: 25% of month/y salary . . . . . . . . . . . . . . (375 ECU/year) 
* means of locomotion (scooter, motorbike or horse)
1 motorbike : approximate/y ....................... . 3,600 ECU 
(taking into account materia/ about to be supp/ied) 
* running costs: .............................. , , 1,000 ECU/year 
* The number of agents along the borders is also depned by country by OAU/IBAR,







How are the agents of a NSES motivated ?
A question: 
How can one keep a permanent field network going whi/e the /ear o/ Rinderpest is 
remote and when a more 'insidious' and '/ess evident' disease, CBPP, makes it d;f/icu/t to 
mob;/ise the /arming partners? 
Blements o/ the answer: 
2 possibilities: 
* Bither with no incentives; the participation in a NSES /orms part o/ the /arming
* 
agents' work. It is a change of /unction: the vaccination over, the time /or 
surveillance has corne! 
Or on the contrary, an incentive is possible. 
ln this case, def;nition of a "lump sum 11: 
* lnconvenience : however much, it risks being considered as a prerogative.
* So a paralle/ evaluation system must be imp/emented: a budget is al/ocated
depending on the results. The agents are remunerated in relation to the 
quality and quantity of work provided. 
General methods o/ attribution o/ incentive allowances 
A budget is allocated per country. The regiona/ supranational unit in consultation with 
the centra/ epidemio/ogica/ unit o/ the NSES o/ each country manages it. 
The sum is spread between the agents invo/ved in the network: co-ordinator, administrative 
agents, f;e/d agents, laboratories, private veterinarians, /armers 
The sum is put at the disposai of the regional unit by the PARC headquarters twice a year 
Advantage o/ regiona/ unit management 
* it is not a privi/ege /or the emp/oyees
* this must not put the country in d;f/icu/ty (it is not an acquired advantage).
The plans are: 
* an evaluation sheet per employee
* an overa/1 evaluation per country
Proposais /or: 
The state agents: 
An allocation corresponding to 25% of the month/y salary is proposed /or d;f/erent leve/s 
o/ the NSBS: Central epidemiologica/ unit, mobile units, provincial units, f;e/d agents 
(observation posts, mobile teams along borders). 
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•:• The private veterinary practitioners : 
Within the exercise of the clients, they will be granted a sanitary mandate /or 
epidemio/ogica/ surveillance o/ Rinderpest (OIE pathway) and the major diseases (CBPP 
in particular). In addition, there will be a mandate /or the active search /or pest virus and 
their participation in the early warning system and emergency preparedness. 
In this respect, an incentive allowance o/ 5,000 ECU per year (corresponding to the 
annual costs o/ an observation post) is proposed. 
•:• The /armers : 
Direct support /or the /armers' associations or the Animal Health Associations wou/d 
be pre/erable in the ftrst place along with a system o/ running costs (purchase of medicines 
etc). 
However, at the individual level one cou/d consider an allowance to motivate the /armers 
to maintain the active search /or the virus, main/y in the zones unaffected by 
Rinderpest. The allowance cou/d be 50 ECU /or each conftrmed alert (Cf above), 
pre/erab/y in the /orm o/ animal care or medicines. 
The methods of granting this allocation to the /armers are as /ollows: 
* The e/igib/e Rinderpest-like diseases, corresponding to a stomato-enteric syndrome
* 
* 
not including Rinderpest, are PPR, IER, BVD/ MD and malignant catarrhal 
/ever, with the exclusion of /oot and mouth disease. 
The establishment of a clinica/ relationship to a Rinderpest /ike disease by the 
veterinary services. 
A conftrmed laboratory resu/t at the regiona/ leve/ demonstrating a disease 
corresponding to the /ist of e/igib/e diseases. 
The /armers' allocation cou/d be distributed direct/y by the national constituent without agreement of the 
regional unit. This wou/d simp/;fy the process and keep up their motivation. 
3.1.6 Evaluation of a NSES 
• Proposais /or pe,formance indicators
In order to evaluate the e/f;ciency of the imp/ementation and the running of this structure, a certain 
number of indicators are proposed: 
•:• The prescribed dead/ine /or the creation of a national network is respected 
•:• For Rinderpest, the status of a country with respect to the OIE pathway is maintained 
(una/fected countries) or advanced {infected countries becoming provisiona/ly /ree). 
•:• The standard sampling methods /or epidemiological surveillance of Rinderpest 
(clinical and serologica/ surveillance ) are effective/y app/ied: 300 herds / strata over 
3 years 
•:• The time /imits /or transmission and emp/oyment of questionnaires (zoo-sanitary 
forms) and reports required by the Central Epidemio/ogica/ Unit are respected: more than 
80% of these documents supp/ied to this unit within the required deadlines. 
28 
•!• Early warning system and emergency preparedness: 
* 80% of ail the agents alertecl within 72 hours
* The Central Epidemio/ogical Unit reacts in the f;e/d within 48 hours {M.obi/e Unit
present)
* Al/ the ident;f;ed c/inica/ cases of Rinderpest-/;ke-diseases are taken into account by the
Central Epidemiological Unit
* To test this indicator (notab/y in the una/fected countries) an early waming
simulation and rapid intervention is envisioned and the reactions of this simulation
are ev�luated
•!• Support /rom national laboratories: all the samples corresponding to Rinderpest-like 
diseases (stomato enteric syndrome) are analysed by the laboratory within time limits 
compatible with the methods of analysis used, and transmitted to the regional 
laboratory. 
•!• ln the case of a conf;rmecl source of Rinderpest, the Director of veterinary services of 
a country immediately warns the headquarters of OAU/IBAR in Nairobi via the 
intennediary of the regional unit as well as the OIE. 
•!• The implementation of an epidemiological surveillance network /or the other dominant 
diseases (notably CBPP) is effective within a time limit of 2 years a/ter the 
commencement of a NSES in a given country 
• External audit of the network
•!• An external evaluation of the NSES is necessary 
•:• It could be carried out by OIE: by groups of countries within the OIE pathway. 
Reminder: the regional unit who co-ordinates the NSES evaluates them continuously. 
3.1.7 Training plan /or a NSES 
• Field agents
0 General training 
* Epidemiological surveillance (NSES)
0 Spec;f;c training 
* Clinical diagnosis, necropsy, inspection of abattoirs
* Samp/;ng (type, packaging, transport)
* Survey /orms
0 ln each country 
For all the executives and technicians concemed {including the private veterinarians): 
* 1st year: 1 week /country
* Following years: 2/3 days of retraining / year
* Cost of one week /or 10 people: . . . . . . . . . . . . . . . . . . . . 5,000 ECU 
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• National laboratory
D Training provided by PARC on/y /or the /ollowing techniques: 
* Rinderpest: a-ELISA, immunocapture
* CBPP: a-ELISA, CFT ,
,,. 
* PARC wilJ not take into account the training o/ agents in "provincial" laboratories
0 A workshop twice during the total duration of the program: 
Cost /or 5 people with consumables and the trainer . . . . . . . . . . 7,000 ECU 
• Permanent education
0 Inter state school o/ science and veterinary medicine o/ Dakar (ISSVM) - Senegal 
0 Faculty of veterinary medicine o/ Debre Zeit - Ethiopia 
D T wice a year in each veterinary school 
D Information on recent techniques 
E.g. PCR, GIS, statistics, in/ectious and parasitic diseases, epidemiology
1 week: 25,000 ECU/ 10 people+ trainers
• Long term training
0 In epidemiology (methodology, statistics, computing) 
D 2 people per country 
D 1 per year in a specialist field (10 months theory + 1 field dissertation as at Debre Zeit) 
D Cost 30,000 to 40,000 ECU/ year /or 1 person 
D Proposed veterinary schools: 
ISSVM Dakar (SenegaD 
FVM Debre Zeit (Ethiopia) 
• Veterinary training /or West and East A/rica
E.g. Annual cost /or one veterinary student at ISSVM of Dakar:
•:• Teaching costs .................................. 4,000 ECU /year 
•:• Subsistence allowance ............................. 1,500 ECU /year 
•:• Air /are and other expenses ....................... , , 1,000 ECU /year 
•:• Total: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,500 ECU/year 
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Two levels o/ intervention are proposed /or the laboratories: 
National laboratorles 
Regiona/ laboratorles (operating /or a group of countries) 
• Within this terminology, the regional supranational laboratories should not be con/used with the
provincial laboratories described as "regional" that are spec;f;c to each country and answerable 
to the national laboratories. 
• The regional laboratories are considered as indispensable strategic relays between the national and
world re/erence laboratories. {Pirbright and Cirad-Bmvt). 
• In order to strengthen the liaison PARC-laboratorles. the consultants propose that PARC
provide _{;nancia/ support for the runnin9 of the national and re9iona/ /aboratorles 
within the ,framework of assi9nments that are entrusted to them in support of the 
NSES. 
3.2.2 Laboratory objectives 
• National laboratories
0 Serological surveillance 
•:• From polyvalent samples of sera the laboratories carry out the serological diagnosis of at 
least 4 diseases considered /or a country such as the dominant existing or 
potentia/ diseases (Rinderpest PPR CBPP etc) 
The idea of "polyvalent" samples permits the considerable reduction of costs due to 
sampling in the field. 
0 Active search /or the Rinderpest virus: 
•:• The laboratories will provide a minima the d;Jferentia/ diagnosis of Rinderpest - PPR 
(Immunocapture) /rom samples that have corne /rom suspected outbreaks of 
Rinderpest. 
•:• These same samples must then be transmitted to the regional laboratories /or confirmation 
o/ the d;f/erential diagnosis with the other Rinderpest-like-diseases. 
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•:• The consultants propose that PARC provides ftnancia/ support to the national 
laboratories on/y to assure the setting up and routine use of the following basic 
techniques: 
Rinderpest: c-ELISA 
lmmunocapture {Rinderpest - PPR) 
CBPP: c-ELISA
CFT (Complement fixation test)
•:• Bach national laboratory is, o/ course, quite /ree, to imp/ement other complementary 
diagnostic techniques (PCR, isolation, identification, and d;f/erentia/ diagnosis) under its 
own means and/ or to equip the provincial laboratories. The additiona/ costs cannot 
be taken into account by PARC. 
• Regional laboratories
0 Analysis of samp/es /rom suspected sources of Rinderpest-like-diseases 
transmitted by the national laboratories /or: 
•:• Confirmation o/ Rinderpest diagnosis 
•:• D;f/erentia/ diagnosis o/ Rinderpest - Rinderpest-like-diseases: 
PPR, BVD/MD, IER, malignant catarrhal /ever, foot and mouth disease 
implementing complimentary diagnostic techniques (PCR, isolation, identification, 
ELISA .. .) 
0 Confirmation of diagnosis for the other dominant diseases (CBPP in particular) 
0 Qua/ity assurance and networking o/ national laboratories. 
0 Proposition of two regiona/ laboratories: 
ln order to li mit the support of PARC to the running costs of these laboratories the consultants propose 
on/y two laboratories, considering the comparative technical and scientific level of the d;f/erent 
candidate laboratories: 
•:• For East A/rica: the Muguga /aboratory in Kenya, the FAO regional re/erence 
laboratory /or Rinderpest. 
•:• For West and Central A/rica the consultants propose: 
* Either the Bingervi//e /aboratory in Côte d 1lvoire, which possesses an
important scientific /ramework /or Rinderpest and the Rinderpest-like-diseases (three
veterinary doctors one o/ whom is a doctor o/ science in addition to senior technicians).
This laboratory is also well situated geographically between West Coast and Saharan
A/rica and Central A/riaa (risk zones o/ the sanitary cordon).
* Or the laboratory of Dakar-Hann (ISRA) in Senega/, FAO A/riaan re/erence
laboratory /or Rinderpest, PPR, CBPP and a/rican horse siakness.
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3 possible levels of support: 
Level 1: countries where the laboratories 
need renovation (water, electricity, re/urbishment 
of some buildings): . . . . . . . . . . . . . . . . . . . 30 to 40,000 ECU in total 
Level 2: countries needing reequipment of laboratory material : 
- ELISA reade; ............................. . 
- small apparatus (pipetman, etc) . . . . . . . . . . . . . . . . . . . . . . . .




Level 3: provision of consumables only:
40,000 ECU/ year over the f;rst 3 years o/ the project
20,000 ECU/ year the next two years /or serological surveillance {Rinderpest, PPR,
CBPP) and immunocapture {Rinderpest - PPR) 
See details of costs later. 





- Congo Democratic Republic,
-Rwanda,
-Sudan.









- CAR (on the way towards rehabilitation)
- Senegal
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0 Costs of providing consumables (/eve/ 3) by PARC 
•:• Estimate of number of sero/ogica/ tests for Rinderpest and CBPP per year: 
* If one considers an average of 25 blood tests per stock, 300 stocks per stratum and two
strata per country, one obtains:
* 
25 x 300 x 2 = 15,000 serologica/ tests per year (over a minimum of 3 years).
The average level of activity of /aboratories can be estimated at 5,000 serologica/ tests
/ year: data that must be taken into account /or the costs in consumables.
On the other hand, one could estimate the number of sero/ogica/ tests for CBPP at
5,000 per year.
•:• Current cost of diagnostic kits: 
* Rinderpest:
c-ELISA (BDSL): 5,000 US $ / 5,000 samples or 1 US $ / sample -
TOTAL: 0.9 ECU/ sample
* lmmunocapture Rinderpest-PPR (BDSL}:
* 
1,000 US$/ 100 samples or 10 US$/ samp/e - TOTAL: 9 ECU/ samp/e
CBPP:
c-ELISA (CIRAD-EMVT): 300 US$/ 400 sera, or 0.75 US$/ serum = 0.7 ECU
/ serum or 2,000 US$/ 4,000 sera or 0.5 US$/ serum = 0.5 ECU/ serum
CFT: approx. 0.6 ECU! serum 
•:• Calculation of costs: 
Serologica/ $urveillance 
* c-ELISA, Rinderpest: 0.9 x 15,000 = . . . . . . . . . 13,500 ECU/ year 
* c-ELISA, CBPP: 0.7 x 5 000 = . . . . . . . . . . . . . . 3,500 ECU/ year 
* CFT (CBPP): 0.6 x 5 000 = . . . . . . . . . . . . . . . . 3,000 ECU/ year 
Sub total ..................... 20,000 ECU/ year 
* Other serological tests and diverse consumables . . . . 10,000 ECU/ year 
TOTAL: . . . . . . . . . . . . . . . . . . . . 30,000 ECU! year 
lmmunocapture: Rinderpest-PPR 
* If one considers approximately 250 suspected outbreaks per year
and 9 ECU per sample, one obtains: 250 x 9 : . . . . . 2,250 ECU/ year 
* diverse consumables ......................... 2,750 ECU/ year 
TOTAL: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,000 ECU/ year 
TOTALCOST: 
* Serological surveillance: ..................... 30,000 ECU/ year 
* Immunocapture: . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,000 ECU/ year 
* Transport of samp/es to the regional laboratory: . . . . . 5,000 ECU/ year 
TOTAL : . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40,000 ECU/ year 
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One can anticipate support /rom PARC to the level of 
40,000 ECU/ year /or the /;rst three years o/ the project 
20,000 ECU/ year over the next two years 
• Regional laboratories:
PARC could consider the /ollowing budgetary proposais: 
0 Staggered renewal o/ existing equipment: . . . . . . . . . . . . . . . 30,000 ECU in total 
0 Equipment /or transport o/ samples and transport costs . . . . . . . 3,000 ECU/ year 
0 D;f/erential diagnosis o/ suspected outbreaks of Rinderpest, confirmation 
of diagnosis /or the other dominant diseases, quality contro/ and networking o/ national 
laboratories 20,000 ECU/ year 
• Networking of national and regional laboratories:
0 Essential/y the support assignments o/ regiona/ laboratories towards national laboratories:
10 missions in total {West A/rica + East A/rica) thus: 
• 8 regional laboratories towards national .............. 30,000 ECU/ year 
• 2 specialists /rom Pirbright and CIRAD-EMVT
towards the regional laboratories . . . . . . . . . . . . . . . . . . . 10,000 ECU/ year 
0 2 annual meetings {West and East A/rica) 
10,000 ECU/ meeting thus ....................... .
TOTAL 
20,000 ECU/ year 
60,000 ECU/ year 
3.2.4 Constitution o/ an A/rican network o/ diagnostic veterinary laboratories: 
• Coordinated by CIRAD-EMVT and Pirbright
• Aims:
* Maintain the technical standard (guarantee the quality o/ services)
* Training
• Other proposed activities:
* Creation of a regional test network
* Edition o/ a report on good laboratory practice
• Provisional costs /or running the network /or each re/erence laboratory (the CIRAD-EMVT and
Pirbright) 
* Edition o/ technical data sheets /o/lowed by the standardization of techniques and qua/ity
contra/ ................................ 5,000 ECU/ year 
* Reception of A/rican students in Europe .................. 10,000 ECU/ year 
* Support missions on demand /rom specialists /rom
re/erence laboratories ............................... 10,000 ECU/ year 
Thus a total of 25,000 ECU/ year /or each reference laboratory. 
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3.3 CONTROL OF RINDERPEST AND CBPP 
VACCINES BYPANVAC 
3.3.1 Generalities 
• This is provided by the PANVAC laboratory (OUA/JBAR) of Debre-Zeit (Ethiopia).
• Al/ the contrai results of batches produced by d;f/erent A/rican laboratories, whether they con/orm
or not, are sent off;cially by P ANV AC to the /ollowing organizations: 
•:• The laboratory that has produced a given batch 
•:• The OAU/IBAR 
•:• The regiona/ coordinators of PARC {Nairobi, Bamako) 
•:• The Buropean Union 
•:• The FAO {Rome, !ta/y). 
• It is up to the regional coordinators to send the PANVAC control results to·the national
components. 
3.3.2 Review of the controlled vaccines 
• When batch numbers of Rinderpest and CBPP vaccines, conforming to international
standards official/y sent to the consultants by the Director of PANVAC, are compared with
the batch numbers actually used by the d;f/erent national constituents it appears clear that in some
countries a high percentage of non-certified vaccines were used in the field.
The absence of PANVAC certipcates /or a given batch of vaccine can have d;fferent 
meanings: 
•:• The national authorities did not demand the certipcate /rom the supplier 
•:• The batch of vaccine was not sent to PANVAC /or contrais. 
•:• The titer of the batch did not con/orm 
•:• The batch was contaminated. 
This situation is unacceptable. 
For each batch of vaccine used in the field as part of the pan-A/rican campaign, the national 
constituents must demand /rom the producing laboratory the corresponding certificate of 
PANVAC conformity. 
3.3.3 Comments 
• The laboratories producing vaccines must destroy their non-conforming batches: absence in general
of a national authority of quality control 
• The regional unit must become more involved in quality contrai of vaccines used in the field and




The regional unit could : 
guarantee the Delegation of the European Union of a country buying vaccine that it would pay the 
supp/iers direct/y /or the doses bought by the country; 
or pay the same supp/iers direct/y by speciftc budgetary /ines attributed to the regiona/ units by the 
PARC headquarters in Nairobi. 
It shou/d be remembered that the system was actual!y in force during the setting up of PARC. 
However, the sale o/ vaccines has gradual!y allowed the regiona/ coordinators to have at their 
disposai the speciftc /unds to buy the vaccines direct/y /rom the producing laboratories. 
Tke con/ormity o/ vaccines is essentia/ to achieve a final eradication of Rinderpest. 
• How much does it cost /or PANVAC to cert;fy a dose of vaccine?
The cost according to "the study of the cost recovery of PANVAC" is about 1,450 US$ based
on a batah of 500,000 doses. This study also proposed a graded tar;f/ with 300 US$ the /;rst
year (1996-1997), 700 US$ the second year (1997-1998) and /;nally, 1,450 US$ the third
year of the project.
Current/y, the real cost is 700 US $ per batch which is:
•t• For a batch of 500,000 doses: 0.84 FCFA/dose
+ For a batch of 1,000,000 doses the cost is reduced to 0.42 FCFA/dose.
For the production of 500,000 doses of vaccine sold for 15 FCFA and 40 FCFA, the 
cost of certification represents a respective surcharge of 5.6% and 2.1%. 
3.4. THE REGIONAL UNIT 
• For the consultants, the regiona/ unit represents a hierarchica/ and /unctiona/ intermediary
necessary between the PARC headquarters and the national constituents. It insures good regiona/
coordination of the NSES and plays a permanent role in evaluation. The objectives of the current
regiona/ units must be rein/orced and extended to other competencies.








Coordinate the NSES and continuously evaluate them (incentive allowance). 
Standardize the data sent in by each country: standard week/y epidemio/ogica/ report (see 
the OIE and FAO examp/es). 
Publish the regional bulletin. 
Biannual regional meetings. 
Network coordinaHon: /ax, telephone & e-mail. 
The regional unit must become more involved in the quality contrai of vaccines used in the 
field and ver;/y the PANVAC certif;cates. 
On the other hand, it cou/d provide among other things, support /or the national laboratories 
(quality assurance) as well as the setting up and assessment of animal hea/th associations. 
• Comments
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* The officia/ declaration o/ a disease must be presented to OIE and the FAO by the veterinary
services of each state and not by the national and regional PARC constituents. 
* The new project coulcJ participate in the creation o/ regional OIE offices whose running costs
are estimated at 90,000 ECU/ year. The cost of running the regional unit wou/d be of 
the same order. 
3.5 LINES OF RESEARCH 
T wo themes of research priorities are presented: 
• Rinderpest:
T wo projects:
•:• One main collaborative project with Cirad-emvt {Montpellier, France) and !AH (Pirbright, 
UK) 
•!• One comp/ementary project !AH (Pirbright, UK) 
• CBPP:
Two EMVT projects:
•!• 1 main project 
•:• 1 complementary project 
3.5.J Rinderpest 
• Main collaborative project Cirad-emvt-IAH
0 This is considered a priority in terms of Rinderpest. The main intention is to study the
possibi/ity of using PPR vaccine instead of the equivalent classic Rinderpest vaccine /or 
bovines and ruminants in a general manner against Rinderpest in emergency interventions. The 
use of a di/ferent vaccine would allow the in/ected animais to be dif/erentiated /rom the 
vaccinated ones (c-ELISA tests /or Rinderpest and PPR). This wou/d /aci/itate the detection 
of serological traces o/ Rinderpest in sensitive animais. This is an important point with respect 
to the risk of the Rinderpest virus spreading where it has declined in East A/rica in 
addition towards Central and West A/rica. 
0 In this respect the project 
•:• Will def;ne the minimum dose of vaccine. 
•!• Determine ;f the cattle vaccinated with PPR vaccine then in/ected with a virulent strain o/ 
Rinderpest are asymptotic carriers of the Rinderpest virus and consequently a source of 
contamination. 
•:• Study the impact of the vaccine in the declared outbreaks of Rinderpest 
•:• Speci/y the duration of immunity conferred. 
•:• Finally, study the technologica/ possibilities of ameliorating the thermostabi/ity o/ the PPR 
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vacc1ne. 
0 Cf Complete protocol and estimate of costs of the collaborative project CIRAD-EMVT-IAH 
in appendix 1 /or a total sum of 1,054,967 ECU. 
The specific budgetary /ines wi/1 be identified in the national constituents /or their participation in 
this project. 
• Comp/ementary project IAH {Pirbright, UK)
0 In this project, several lines o/ research and development oriented towards the study o/ the 
pathological power o/ the Rinderpest virus and the epidemiology o/ the disease are proposed. 
0 It is suggested, first, that ;J the attenuated strains of Rinderpest identified over the 
fast few years persist in the wi/dl;fe, their pathogeni city could increase a/ter 
serial passage in cattle. 
An experimental protocol in cattle, sheep and goats is proposed to study this hypothesis. 
0 In addition, an experimental protocol is proposed: it concerns the study o/ the excretion 
of the Rinderpest virus in cattfe in/ected with three strains of d;f/ering virulence. 
0 Two protocols are proposed in molecular epidemiology: 
•!• PCR detection of the viral genome in the vaccine 
The genome has been identified in the field in Tanzania and Kenya /rom ocular 
ecouvillons; these results are worth conprming. 
•!• Field validation of the Pen-side test (clearview test) 
This rapid diagnostic test developed by the IAH has yielded very promising preliminary 
results and requires field validation at this stage. 
This quick and easy test based on the use of monoclonal antibodies shows a per/ect 
correlation with PCR. 
It wi/1 allow the field surveillance methods to be strengthened. 
0 Pirbright then proposes the appointment of a grant to an A/ricarz scientist to 
ensure the liaison PARC-IAH in the fields of epidemiology, molecular characterization in 
addition to training of other A/rican scientists. 
0 Cf Complete protocol and cost estimate o/ project IAH (Pirbright) in appendix 2 /or a total 
sum of E135,019 
or approximately . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205,000 ECU 
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3.5.2 Contagious bovine pleuropneumonia 
• Main project Cirad-emvt
D This is considered a priority in terms of CBPP. Its main objective is the improvement 
of current vaccines. 
This presents the following inconveniences: 
•:• Duration of post vaccination immunity is less than 1 year. 
•:• Live vaccines: problems of stability of the vaccine strain. 
•:• In certain cases problems of safety in the target animal (taurins in particular). 
•:• .Ahsence of vaccination marker. 
D The research themes are as follows: 
•:• Ident;f;cation of genes coding for the virulence factors. 
•:• Characterization of the cellular immune response a/ter vaccination or infection. 
•:• Ident;f;cation of antigens inducing protection. 
•:• Selection and cloning of the genes coding for these antigens. 
•:• Selection of expression vectors and construction of thermostable, marked, 
recombinant vaccines expressing the proteins involved in the protection. 
•:• Selection of adjuvants of immunity. 
•:• Field trials with candidate vaccines. 
-evaluation of safety
-of protection (efficacy tests by proven vaccines)
-of the duration of immunity
Cf Complete protocol and cost estimate of project CIRAD-EMVT in appendix 3 for a total sum 
of 644,400 ECU. 
• Complementary project CIRAD-EMVT
D Its objective is the study of the e/!iciency of antibiotic treatments used in cattle su/fering 
/rom CBPP. 
Antibiotias are widely used by farmers in this situation under non-standard conditions. The problem of 
their actual eff;cacy and cost is regularly raised by the authorities and veterinary institutions. This 
subject merits a spec;f;c field and laboratory study (methods of treatment, impact on chronic carriers.) 
D Cf Complete protocol and cost estimate of the project CIRAD-EMVT in appendix 4 for 
a total sum of 100,000 ECU. 
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3.5.3 Total /or ail the projects 
Rinderpest ................................................ 1,054,967 
+ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205,000 




TOTAL ............................................... 2,004,367 ECU 
3.5.4 Hierarchy of priorities 
ln the f;rst place, it is proposed: 
· • Rinderpest
0 . Use of the PPR vaccine 
To protect ruminants against Rinderpest 
•:• IAH Pirbright: 443,190 ECU 
•:• Cirad-emvt: 611,777 ECU 
0 Field validation o/ the pen-side test 
•:• IAH Pirbright: 109,695 ECU 
• CBPP
0 lmprovement of current vaccines 
•:• Cirad-emvt: 644,400 ECU 
• GRAND TOTAL 1,809,062 ECU







USE OF PPR .VACCINE TO PROTECT RUMINANTS AGAINST 
RINDERPEST 
I) AIM:
The EMPRESS expert consultation which was held in Roma in July 1997 has 
recommended the use of PPRV vaccine instead of the rinderpest one to vaccinate animais 
against rinderpest in endemic areas. The intention for the use of this heterologous vaccine is 
to ease the detection of serological traces of rinderpest virus in susceptible animais. This is 
very important when facing mild rinderpest virus strain which might circulate in susceptible 
animal population without causing significant clinical signs. The important prerequisite for 
such strategy is the availability of data which prove that PPR · vaccine is effective for the 
protection of animais, particularly cattle, against rinderpest. The aim of the present project 
is to provide the information when deciding to shift from homologous to heterologous vaccine 
in rinderpest eradication campaigns. 
ID Background: 
Because of its high mortality and high morbidity rates, at least in its classical 
form, rinderpest is one of the most dreaded animal diseases. Concerted international efforts 
have confined this disease to few foci in Africa, the Middle East and Asia. In (!lis way, they 
have contributed to reduce losses due directly to rinderpest itself. However, in endemic areas, 
it still remains a serious cause of economic losses araising from: 
- the exclusion of the infected country from international animal trade,
- the negative impact on tourism incorne when visits of natural parcs
bave to be restricted during rinderpest outbreaks in wildlife. 
- the necessity, in some circumstances, to maintain vaccination
campaigns to control the disease. If the cell culture attenuated vaccine currently used is not 
expensive itself, the logistics which are implemented during rinderpest vaccination is costly. 
Because of this economic importance of rinderpest, efforts are being made to 
eradicate this disease froi:n the world. For such endeavour, an OIE expert consultation meeting 
outlined in 1989 a serie of steps which start from "the intention of rinderpest eradication 
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(vaccination)" to "the provisional freedom from disease (cessation of vaccination)", "freedom 
from diseasen and finally "freedom from infection". This last step implies that no rinderpest 
. antibody should be detected in susceptible animais for at least two years of intensive 
epidemiosurveillance. 
Following the rinderpest mass vaccination which has been conducted since 
1980's, in many areas in Africa, the Middle East and Asia, no disease case has been recorded 
for years. The authorities of the concemed countries are ready to declare themselves 
provisionally free from the disease. Unfortunately, some rinderpest foci still exist in countries 
in which vaccination campaigns should be continued. The same status should be maintained 
in disease free areas which are at the borders of the infected ones in order to serve as a buffer 
to prevent rinderpest from escaping into large vulnerable zones. ·There is no possibility now 
to distinguish antibodies arisen by wild type of RPV from those obtained after vaccination with 
the attenuated RPV strain. Therefore, the use of this latter virus might overlook the presence 
of a mild RPV which is not causing serions clinical symptoms but which could be detected. 
easily by a serosurveillance. Thus, there is a need to conciliate the necessity of controlling 
rinderpest in infected. and buffer zones by vaccination with the objective to go very quickly to 
the situation of "NO RJNDERPEST ANTIBO DIES IN SUSCEPTIBLE ANIMALS". This 
conciliation can be obtained by the use of a vaccine distinguishable from wild types RPV. The 
PPR vaccine strain is a good candidate for such purpose becalise a test is available for the 
detection of PPR specific antibodies (Libeau et al., 1995). Peste des petits ruminants virus 
(PPRV) and rinderpest virus belong to the Morbillivirus Genus in the Paramyxoviridae family. 
This genus regroups closely related viroses and includes measles virus (MV), canine distemper 
(CDV), phocine distemper virus (PDV), dolphin and porpoise morbilliviruses (DMV and 
PMV). Mornet et al. (1956), Gibbs et al. (1979) bave shown that cattle given virulent PPRV 
did not show an overt disease but are protected against a challenge rinderpest virus. In the 
same way, small mroioaot given rinderpest virus are protected against PPR (Gibbs et al.; 
1979). This crossprotection between RPV and PPRV has been exploited with success for many 
years to protect sm.all mroioaots against PPR by the use of live attenuated rinderpest virus as 
heterologous vaccine (Bourdin et al., 1970; Taylor W.P., 1979; Bonniwell M.A., 1980). In 
1995, Couacy et al. bave demonstrated tbat attenuated PPRV can be used to protect goats 
against virulent rinderpest �ection. However this reported challenge had been carried. out .3 
3 
weeks after vaccination. There is no report concerning a long term immunity provided in small
mrninants by PPR vaccine against rinderpest. Neither is data relative to the use of this vaccine 
_ in cattle available. Morbilliviruses are epitheliotropic and lymphotropic viroses. Rossiter and 
W ardley (1985) have demonstrated that virulent RPV grows more readily in bovine than 
in small ruminants lymphocytes whereas virulent PPRV grows better in sheep and goats 
lymphocytes. However there is no significant difference in the infection rate of both types 
of lymphocytes by the attenuated rinderpest virus, a rate wlûch is vecy low in comparison 
with those obtained with virulent viroses. Such experiment which can provide preliminacy 
information on the mechanism of the immunity against PPR or rinderpest bas not been carried 
out yet with the attenuated PPRV. Thus·, preliminary investigations should be carried out to 
prove the efficacy and safety of this virus as a heterologous vaccine against rinderpest. The 
informations expected from these investigations are relative to: 
-the minimum effective dose,
-the status of vaccinated animais subsequently infected by virulent rinderpest
virus (are they asymptomatic RPV carriers and, thereby, sources of contamination?), 
-the effect of vaccination during an outbreak,
-the duration of immunity.
The present project aims to undertake experiments in view to provide information 
on the above mentioned subjects. Another objective is to improve the thermostability of 
the attenuated PPRV- vaccine by the same as done by Mariner et al. (1990) for tissue 
culture rinderpest vaccine. 
PROTOCOLS 
1) Determination of the minimum infectious dose with the miriimum effective dose of
PPRV vaccine in cattle and goats. In order to provide an easy means to assess vaccine potency 
of the tissue culture attenuated rinderpest virus, Plowright (1962) has carried out a comparative 
titration in parallel in prirnacy BK cells and cattle. He found identical results in both systems. 
This suggested that cell culture can be a substitute for cattle in assessing the potency of 
attenuated rinderpest vaccine produced in BK cells. Taylor and Best (1977), with the objective 
of using rinderpest vaccine in goat for protection against PPR, undertook the same type of 
comparative titration and found that 1()5·4 TCID50 of tissue culture rinderpest vaccine (TCRV) 
corresponded to 1()5.2 goat ID50. Based on that result, and although any relationslûp between 
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the immune reponse to TCRV and the ability to witbstand challenge by PPRV was not clearly 
established, they proposed to use BK cells for the prediction of immunising efficacy of this 
vaccine in goats against PPR. Martrenchar et al. (1997) found that at least lCP.6 TCID50 of 
attenuated PPRV are sufficient to protect goats against PPR challenge. Unfortunately, their 
experiment was incomplete since the minimum effective dose was not determ.ined. Experiments to 
be carried out during the present project wil1 fill in this gap. A virus stock will be titrated 
simultaneously on vero cells, goats and cattle. To establish a relationsbip between immunising 
dose 50 (IDSO) and the vaccine efficacy, the inoculated animais will be challenged. A tenfold 
dilution series will be made from a virus stock and and four dilutions with estimated. titres 
ranging from 100 TCID50 to O will be titrated on vero cells. The same virus dilutions will be 
inoculated to cattle and goats: 5 cattle/dilution but 10 goats/dilution. The animais will be 
followed clinically with serum collection at 0, 7, 14 and 21 days post-vaccination. After the last 
bleeding, the animais will be challenged with virulent RPV (all cattle and half the number of 
goats/dilution) and with virulent PPRV for the other half of goats (see table 1). The challenge is 
carried out by subcutaneous route. Each group of animais is in individual loose box and is 
handled in such a way to avoid transporting possible excreted virus from one group to another. 
Frorn day O of challenge to day 14, the animais are bled every two days for serum and 
lymphocyte collection. Nasal and ocular swabs are collected with the same frequency. 
Lymphocytes and swabs will be analysed by PCR for the presence of virulent virus (detection of 
challenge virus multiplication and excretion). The collected serums will be titrated against both 
PPRV and RPV. 
OUTPUTS of this experiment: 
-relation of TCID50 and immunising dose (IDSO) for goats against PPR or against RP,
-relation of TCID50 and immunising dose (IDSO) for cattle against RP,
-relationsbip between ID50 and minimum effective dose in ca�e or goats against RP,
-recomm.endation of dose to be used for routine vaccination.
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Table 1 
animal species groupn° vaccine dose challenge virus 
cattle 1 100 RPV 
cattle 2 10 RPV 
cattle 3 1 RPV 
cattle 4 0 RPV 
goats 5 100 RPV 
goats 6 10 RPV 
goats 7 1 RPV 
goats 8 0 RPV 
goats 9 100 PPRV 
goats 10 10 PPRV 
goats 11 1 PPRV 
goats 12 0 PPRV 
2) Status of PPRV vaccinated animais (goats and cattle) and challenged by intranasal
route. 5 goats and 5 cattle will be vaccinated with recommended PPR vaccine dose. After 3
weeks, they will be challenged intranasally with virulent rinderpest virus (Saudi strain). The 
. .. 
day following this challenge, each group of species is moved to new loose boxes. They are 
maintained with two in-contact susceptible cattle for each box (cattle are better th.an goat as 
sentinels for rinderpest, see couacy et al., 1995; Anderson et al., 1990). Animais are daily 
followed clinically. Swabs and blood (serum, lymphocytes) are collected every two days in 
view to detect, by PCR, challenge virus multiplication and excretion. Personel who handle 
vaccinated and challenged animais are different from those bandling the control one in order 
to avoid crosscontamination by animal attendants. The animal surveillance is carried for 3 
weeks if necessary. 
OUTPUT OF THIS EXPERIMENT: determination whether or not PPRV vaccinated animais 
could be asymptomatic rinderpest carrier. 
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3) Detennination of delay between vaccination and effective protection against-RP. The
FAO experts wouid like to recommend the employment of the attenuated PPRV as 
• 1 
. heterologous vaccine in both infected and buffer zones. In case of its use in infected zones, 
some animals will be vaccinated white in rinderpest incubation or will be infected soo after the 
vaccination. The present ex:periments are designed to predict the outcome of the disease in such 
situations. 
-Short tenn challenge.Four groups of vaccinated animais, each composed of 5
goats and 2 cattle, will be challenged by intranasal route with virulent RPV at 2, 5, 7 and 14 
days post- vaccination. The day following the challenge, 2 sentinel cattle are introduced into 
each group. A fifth group, composed of non vaccinated susceptJ.ole animals (5 goats+2 cattle) 
will serve as control for the challenge. Each group is maintained separately in a loose box. 
The sentinel animais are never handled to avoid mechanical .contamination. The other animais 
are followed clinically with the collection of blood and nasal-ocular swabs every two days post­
challenge. The clinical survey is carried out for 2 weeks (the use of RPV Saudi usually leads 
to the death of control animais in one week). 
-Prechallenge followed by vaccination. The scheme of this experiment is similar
to the precedent but here the vaccination follows the challenge. Four groups of RPV challenged 
animais (by intranasal route), each composed of 5 goats and 2 cattle, will be vaccinated at 0, 
2, 5, and 7 days post-challenge. The RPV strain to be used in the challenge should have an 
incubation period longer than 3 days (/RPV Nigeria Buffalo). This condition excludes the most 
virulent RPV strain: the RPV Saudi. The day following the vaccination, 2 sentine! cattle are 
introduced into each group. A fifth group, composed of non vaccinated susceptible animais (5 
goats+2 cattle) will serve as control for the challenge. Each group is maintained separately 
in a loose box. The sentine! animais are never handled to avoid mechanical contamination. The 
other animals are followed clinically with the collection of blood and nasal-ocular swabs every 
two days post-challenge. The clinical survey is carried out for 2 weeks. 
OUTPUTS OF THESE EXPERIMENTS: Information on the short term protection provided 
by the vaccine against rinderpest are provided. 
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4) Study of the cellular immune responses induced by the PPR vaccine and the duration of
provided imnuuzity. The immunity provided by morbilliviruses is related to both humoral and
cellular mediation. Therefore in order to evaluate the effectiveness of the PPR vaccine, both
types of immune responses will be studied in cattle and goats on a three year period. By
comparing the responses obtained in goats and cattle, the antigens involved in each case and
the persistence of the PPRV-specific memory T-cells, it should be possible to predict the
effectiveness of a PPR vaccine in protecting ruminants from PPR and RP. To that effect, 30
cattle and 40 goats will be vaccinated and maintained in a disease-free condition until needed
for the challenge experiment. Nevertheless, 10 PPR/RPV susceptible goats will be maintained
with the vaccinated animais. They will serve as controls for an accidentai introduction of PPRV
(or RPV).The kinetics of the cellular immune responses induced by the PPR vaccine will first
be studied during the first 3 months of the experimentation. Identification of the subsets of
recruited lymphocytes and of the viral protein(s) involved will be achieved. To that effect, 5
cattle and 5 goats will be bled on a weekly basis for 3 months. Peripheral blood mononuclear
cells (PBMC) will be purified by a Ficoll:-Paque density gradient. PBMC will be
phenotypically characterized using monoclonal antibodies specific for bovine or goat leukocyte
differentiation antigens. The evolution of the various cell populations (B-cells; CD4 T-cells;
CD8 T-cells; g/d T-cells and monocytes) and of their state of activation will then be studied
by .. flow cytometry. The lymphotropism of the PPRV in cattle and goat PBMC will also be
studied by the same technique. The responsiveness of the PPRV-primed T-cells will be checked
by performing lymphoproliferation tests (LP). PBMC from cattle and goats will be stimulatecl
in vitro with PPRV and RPV. Identification of the protein(s) involved in T-cell activation will
be achieved using the whole virus and the various purified proteins. Since we are dealing with
intracellular organisms, the cytotoxic T-cell (CD8) response should also be evaluated in terms
of functionality. The function of the CD8 T-cells is to lyse autologous infectecl cells, presenting
the recognized antigens on its surface. Therefore, for this test, autologous cells will be infectecl
in vitro by PPRV or by RPV and labelled in order to follow the lysis. To avoid the use of
radioactive component (51 Cr), which is the classical method, the target cells will be labelled
with a fluorescent component (calcein). The CD8 cytolytic activity will be determined by the
calcein-release, due to the lysis of the target cells after incubation in vitro with the CD8 T­
cells, measured by a cytofluorometre. For the humoral immune response study, serum
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collection will be done-every two months until the six.th month for each animal and at the day 
of every challenge. 
The persistence of the PPRV-specific memory T-cells will be followed after each 
challenge during a 3-year study and their usefullness as protective against RP. 4-5 cattle and 
5 goats will be withdrawn from the group and cballenged with RPV Saudi at 6, 12, 18, 24, 30 
and 36 months post-vaccination. The day following the challenge, they will be housed in new 
boxes with 2 cattle sentinels. Two otber cattle, in a separate box, will serve as contrais for the 
challenge. Clinical survey will be carried out for two weeks, with collection of nasal-ocular 
swabs every two days with blood collection for serum and lymphocytes. These latters will 
serve for the study of the persistence of the PPRV-specific memory T-cells. After slaughtering 
the animais, the lymph nodes will be collected too. Circulating (blood collected cells) and 
resident (lymph nodes cells) PPR-specific memory T-cells will be stimulated in vitro (LP tests) 
with PPRV, RPV and witb the appropriate purified proteins. These cells will be phenotypically 
studied by flow cytometry and functional tests will be carried out for CD8 memory T-cells. 
If the PPRV-primed T-cells respond similarly to PPRV and RPV and according to the 
clinical survey, this will demonstrate that the PPRV-specific memory T-cells can induce a 
cross-protection against RP. 
The duration of immunity provided by the attenuated PPRV against rinderpest will be 
analysed for a 3 year period (a total of 6 challenge experiments at 6,12,18,24, 30 and 36 
months post vaccination). However, if at the end of the first year, the results obtained are 
similar between PPRV and RPV in terms of subsets of lymphocytes recruited and protein(s) 
involved and since it is known from previous studies that the attenuated PPR vaccine can 
protect goats for at least 3 years, one might extrapolate that these PPRV-memory T-cells can 
also protect against RP for 3 years. Thus, cattle vaccination with PPRV vaccine could be 
recommended at the end of the first year of the project. 
OUTPUTS OF THESE EXPERIMENTS: 
-long term duration of immunity by PPR vaccine against RP;
-identification of the subset of lymphocytes stimulated by the PPR vaccine in
small ruminants and cattle and i;-esponsible for the immunity. 
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5) Production of a thermostable PPR vaccine. PPRV, like all morbilliviruses, is thermolabile.
The half-life of PPRV in liquid formas been estiroated to be 2.2 mn, 3.3 hours, 9.9 days and
. 24.2 days at respectively 56, 37, 4 and -20 °c (Rossiter and Taylor, ). There is no data 
available about the virus in the IyopbUized state. However it could be assumed that the PPRV 
thermostability in that state wilI not be different from that of RPV. Even though the attenuated 
PPRV is effective, its use in RP/PPR vaccination campaign will require a constant maintenance 
of the cold chain in all steps of the process. This necessity will make the campaigns costly. 
Therefore, in order to eliminate the necessaty of the cold chain, it is intended to develop a 
thermostable PPR vaccine based in the same manufacturing techniques which were successfully 
used with tissue culture rinderpest vaccine (Mariner et al., 1990). The vaccine, once produced, 
will be stabilized in different mediums which were tested by Mariner et al. (1990): LS, BUGS, 
LGS. Tuen it will be freeze dried in a total cycle of 72 or 76 hours with vacuum regulated at 
10 mTorr.or lOOmTorr. The stability ofthese products will be tested, in lyophilized fonn and 
also when reconstituted in diluent (physiological water), at the following temperatures: -20, 
+4, 37, 42 and 50 °c. The virus recolted at each point will be titrated on vero cells in 
microwells plate. 
OUTPUTS OF THE EXPERIMENT: obtention of a thermostable PPR vaccine. 
CONCLUSION 
Different rinderpest vaccination campaigns are in a consolidation phase �iming at the 
eradication of this dreaded animal disease. The use of an effective vaccine which can be 
distinguished serologically from the wild type rinderpest virus will improve the confidence in 
the seroepidemiosurveillance and will speed up the steps leading to the eradication of the 
disease. The PPR vaccine, which has been proven to be safe in PPR control, might be used 
successfully as a heterelogous vaccine against rinderpest. Tests are available for this specific 
distinction from rinderpest viruses. This present project is expected to provide immunological 
�d clinical tests data for an eventual use of PPRV vaccine in rinderpest eradication campaign. 
The experiments are designed to test the duration of iromunity on a period of 3 years. 
However, if the one year imm.unity test is positive, it could be advised to employ this vaccine 
for routine use in rinderpest control campaign without waiting for the 3 year tenn immunity 
results. Since it is known that sheep and goats given PPRV vaccine are protected for at least 
10 
3 years (Colas et al., unpublishecl data), and if the comparative analyses prove that there are 
identical immnnological mechanisms in goats and cattle with PPRV vaccine, one can expect 
to have the same long term immunity in both species. 
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Additional support staff 
Additional support staff in European laboratories are 2 scientists and 1 laboratory technician. 
An imm.unologist and a veterinarian are needed for the 3 years of this project. The 
immunologist will be in charge of the study conceming the cellular immune responses induced 
by the PPR vaccine and the RP vaccine. He will stay at CIRAD-EMVT for the main part of 
his work and will go overseas to collect samples after every challenge. 
The veterinarian will spend 1 year at the IAH-Pirbright laboratory to follow all the 
animal experimentations. The next 2 years, he will corne to CIRAD-EMVT, as responsible for 
the developrnent of the thermostable PPR vaccine and will be in charge of every field trials 
overseas. 
The laboratory technician will be ernployed for two years by the IAH-Pirbright 
laboratory to perform all the serological assays corresponding to the animal experimentations. 
Additional equipment : 
* CIR.AD-EMVT
- One cytofluorometre :
The aim of this project is to study the cellular immune response of intracellular 
organisms. In this contexte, the cytotoxic T-cell (CD8) response is mainly involved in the 
immune response. Therefore, the CD8 response bas to be evaluated, not only phenotypically 
in terms of frequence and activation state but also in terms of functionality (lyse of autologous 
infected cells presenting the recognized antigens on its surface). In order to avoid the use of 
radioactive component (51 Cr), which is the classical method, the cytotoxic assays have to be 
performed with target cells labelled with a fluorescent component (calcein). The CD8 cytolytic 
activity will then be determined by the calcein-release which is measured by a cytofluorometre. 
* IAH-Pirbright laboratory
- One -70°C freezer:
A -70°C freezer is needed to keep cells, viruses and samples taken from the animal 
experimentations. 
13 
Financial cost (in ECUs) for CIRAD-EMVT 
lrst year 2nd year 3rd year Total 
Personnel 
immunologist 50,250 50,620 53,654 154,524 
veterinarian nil 50,620 75,750 126,370 
(oversea stay) 
Conswnmable 45,460 47,750 50,130 143,340 
Equipment 27,280 nil nil 27,280 
Travel, meetings and conferences 
9,100 7,600 7,600 24,300 
Project coordination 8,000 8,000 8,000 24,000 
Unforseen expenses 3,000 3,500 3,500 10,000 
Sub-total 143,090 168,090 198,634 509,814 
Overheads 28,618 33,618 39,727 101,963 
Total 171,708 201,708 238,361 611,777 
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Financial cost (in ECUs) for IAH-Pirbright Laboratory 
lrst year 2nd year 3rd year Total 
Personnel 
veterinarian 47,740 nil nil 47,740 
Technician 32,820 34,130 nil 66,950 
Consommable 15,000 15,000 nil 30,000 
Equipment 6,000 nil nil 6,000 
Animais 
68 catt1e 142,580 nil nil 142,580 
140 goats_ 42,220 nil nil 42,220 
Unforseen expenses 14,100 11,100 nil 25,200 
( + advertisement and shipment cost)
Travel, meetings and conferences 
3,830 4,800 nil 8,630 
Sub-total 304,290 65,030 nil 369,320 
Overheads 60,860 13,010 nil 73,870 






Total cost of the project (in ECUs) 
lrst year 2nd year 3rd year 
171,708 201,708 238,361 
365,150 78,040 nil 
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APPENDIX2 
· As th� Pan Afücan �derpest Camp.aign (PARC) progresses there are still some unresolved
questions to be arJS1Nered regarding the pathogeniciry and epidemiolôgy of the disease. There
have been suggestions tbat <Lmild" strains may persist in wildlife but become more
pathogenic after seria;I passage in cattle but there is very little evidence to suppon this.
Recent tecbnological 'advances such as the polymerase ch.a.in reaction (PCR) have increased
the sensitivity of diagnostic assays and resulted Ïn the detection of virus genome in a numbcr
of :::ye swabs from csttle in Kenya and Tanwma. Follov.-ing nucleoride sequencing of the
PCR prod_ucts, som�ôf the positive res�ts may be due to the presence of vaccine virus R._NA
in the cye s-wabs. Thi$ was unexpected based on previous reports and de-sçrves fvrther
investigation if we are to correctl y interpret diagnostic resulrs: Preliminary development of a
rapid pen-side diagno·stic assay shows grcat promise but the test requires fur.ber field rrials.
This project is design�d ta investi gate these impor�t issues which have a major bearing on
the fumre strategy of? ARC.
There are also other �ctivities, which although not research projects are equally essential to 
the success of PARC.'. Molecular cb.aracterisation of rinderpest virus st:rain.s has offered the 
opportunity for tracqi.g the origïn of outbreaks and has led to a greater understanding of the 
epidemiology of the disease in East Africa and elsewhere_ Continued funding îs required to 
support this e,..-pensiv� service so essential to PARC, along with funds for large animal 
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experimenta.tion to esœhlish the pathogenicity of newiy isolatcd strains of virus. Closely 
allied to ail of these investigations is the need to train and èôntinually update African 
scientists in the latest tecbnical advances, especially those who are employed in the Regi onal 
Reference Centres. Itwould be bigbly appropriate if the projects and duties descnbed below 
were can:ied out at the FAO World Reference Laboratory for Rinderpest (WRLR) by an 
Afriean scientist actively involved in PARC. This could be accomplished in the form of a 
biennfally renewed EU-PARC Fellowship which would not only increa.se our understancling 
of the disease but âlso provide invaluable specialist training leading to future self­
sustainability. 
1. Se rial passage of "mild strain'• of rinderpest virus in cattle
Introduction 
Contrazy to some reports, the rinderpest virus strain isolated. from eland in Nairobi National 
Park, Kenya in 1996 does not result in a mild di.$ease in ail ca.ttle. Following experimental 
infection of four cattle1 three cattle showed mild clinical signs but one sho\).,'ed füll clinical 
rinderpest and died at 18 days post infection ( dpi). The question remains, whetber serial 
passage of this virus .i.t1 cattle 'Will increase its virulence even further. The PARC 
epidemiologis� Paul Rossiter, in a persona! commwrication reported that he had observed 
full clinical rinderpest lh'Ïth the tbree "'D�s" ( d� discharge and diar.rhoea) in cattle 
following the Nairobi. Game Park outbreak. and suggested that the strain had become more 
virulent after passage·in cattle. Since then there hav� been COitflietittg reports from the field 
and the hypothesis tbàl; wil.dlife strains can become increasingly virulent for cattle after serlal 
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passage reqnîres .furlher investigation. 
Following otrtb:reaks in Kenya and Tan1ania the main strategy bas been mass vaccination of 
ail cattle. Tiris does not take into account any possible involvement of sheep aud goats. 
Although not thoughtto be a major factor in the past, further work is required to establish the 
role of small ruro.iuants -with this particular strain. Studies are required to determine the 
susœpubility of sheep and goats to the current strain and establish if transmission takes place 
between cattle, sheep:�d goats. This should be linked to the experiments on pa.s.saging the 
eland strain through catde and may have major implications on tlle eradication strategy used 
in this region.. 
B..perime,ual design 
A minimum of :five cattle per pas.sage will be required due to variation in animal 
susceptib11ity. Five cattle will be infected subcutaneously Vv'ith a suspension of the original 
Kenyaleland/96 isolate. Cattle will be housed 2 or 3 to a box dependent on animal size and 
examined daily for clinical signs. Blood saxnples will be collected daily to monitor the 
humoral immune response. Duplicate eye swabs Vvill be collected every two days for 
evaluation of the pen..:.side diagnostic test and also for PCR. l�y PCR produCtS will be 
nucleotid� sequenced. Assuming that some animals develop clinical si� materlal from the 
:mima] sho't'r'Ïng the most severe clinicat signs wil1 be collected and passaged into a further 
five cattle (ÎÎno anîmals develop clinical signs a furt:her five cattle wiil be infected with the 
original material). This process will be repeated four times. 
Simultaneously 2 sh� a.nd 2 goats will be infected with the original K.enya/eland/96 strain.
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The animals will be monitored for clinical signs and blood samples and cyc swabs collected. 
If sheep or goats develop clinical signs the ms.terlaI will be passac,ac::d into a fùrther 2 sheep 
and 2 goats. If no clinical signs are evident, material from the cattle passage wil1 be used. 
If /when cattle show clinical signs suscepti"ble sheep and goats will be intro(luced into the 
aniros.1 box. for transmission studies. Similarly, if sheep and goats show clinical signs, or 
during the last passage in sheep and goats, susceptible cattle will be in:troduced for evidence 
of transmission. 
Outputs 
1) Establish if serial passage of «mild" strains increases their pathogenicity.
2) Establish suscepn�ility of sheep and_goats to Kenya/eland/96
3) Estab!ish if transmission ofKenya/eland/96 virus takes place between cattle, sheep and
goats 
4) Further our undersœnding of the role of sheep and goats in the epidemiology of rinderpest
i. Transmission experîments and investigation into amounts of virus
excreted by animais infected with dîfferent str.aî11S. 
Introduction 
Little is know.n aboutlthe transmission rate of the '1nild" strains of rinderpest virus. This bas 
a major bearlng on thé size of the cattle population ne(:ded to maintain the vi.n:cs in the field 
(i.e. R, value). If an estimate of the transmission rate for different strams could be 
determined, these fi� could be introdnced into the computer model to give a more 
4 
meanûigful analysis. If the Kcnya/elaud/96 strain shows increased virulence following 
passage in cattle (see experiment 1) then the transmission rates of the 1ow and high passage 
viruses could be compared. These in tuai could be cornpared to a more virulent strain. If the 
Kenyan strain shows no detectable mcrea.se in virulence" then it could be compared to two 
other straîns of epîdemiological interest Eye and nasal swabs samples will l>e coI1ected and 
titrated in tissue culture to estima.te the amount of virus excreted at the varions stages of 
infection by the va.rio us strains. This may give a correfation between the amount of virus 
e..'\:creted and the transmission rate. 
Experimental design 
One steer each will be infected with ea.cb of the th.ree rinderpest virus strains and maintained 
in separate housing. Four susceptible s�ers \\'Ïll be introduced into cach box to allow contact 
nansmissfon. Ocular·�,d nasal s-wabs wilI be colleeted dai]y. BJood samples will be 
collected for detection of the humoral antibody response and rectal tempe.rotures will be 
recorded daily. The ocular and nasal. SY..-abs "Will be ritrated in tissue culture to compare the 
amount of virus excrered for each strain of virus. 
Outputs 
1. Establish the duration of virus excretion in ca:ttle following i.nfection-with. three .different
virus strains. 
2. Evaluate correlation between the level of virus excretion and the transmission rate.
:,. Generate data for inclusion in the computer model to provide more me:mingful analysis. 
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3. Detection of vaccine virus genome in eye sw-abs by PCR following
vaccination 
Intrqauctiott 
During the recent outbreab in Kenya and Tanzania eye svtabs submitted for diagnosis bave 
been positive by the C4"Clearvievl' pen-side test attd also by PCR. Subsequent nucleotide 
sequencing has shown the vüus to be similar to Kabete 0, the vaccine strain. This could be 
explained by the aniro� Is being recently vaccinat.ed in the face of an outbre� but it bas 
alv..'ays been believed:that the vaccine virus bas lost its epitheliotropism and should not 
generalise sufficiently to reach the eye. Alternatively, a field strain may be circulating which 
bas a similar nucleotiae sequence to the vaccine strain. Because of the importance of PCR 
using eye swab material in the diagnosis of rinderpest, particularly that due to mild strains, 
experiments are reqwred to determine-if vaccine virus can be detected in eye swabs 
follo'WÎ.ng vaccination and if so to establish when and for how long samples remain positive. 
Expenine1tûzl design 
Ten cattle will be vactinated using the RBOK attenuated vaccine. Duplicate eye swabs will 
be collected daily over one month and tested for RPV antigen and RN..� using the pen.side 
diagnostic assay and PCR. All PCR products wlll be nucleotidê sequencecL 
Outputs 
1) Establish if /how long rinderpest virus is p.resent in. the eye following vaccination.
2) Clarifythe significance of finding virus with a nuoleotide sequenee similar to the vaccine
strain in eye swabs collected În both Kenya and Tanzanfa. 
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4. Field trials of p:en-side diagnostic tests
Prototypes of a pcm-side diagnostic test based on Clea:rview technology bave been field .. 
trialed in Pakistan and to a lilltited extent in TanZ3Dia. The results bave been promîsing and 
devices have been used successfully i.n both countries to diagnose rinderpest. The test is 
currently being optimised and an alternative production Company has bcen identified. Funds 
are required to underrake more extensive field trials. Once vali®ted and adopted for use in 
P ARC1 fonds should be a.llocated for purchase of the devices for national field services, 
�cularly ofthose.countries considered most at risk. The use of tbis technology would also 
pro;,ide support for gôvermnent declarations to OlE for :freedom from disease� by provicling 
an efficient surveillance system. 
It is envisaged that :fiêld trials wil1 take -place in a. country in East Africa where disease is 
present at the appropiiate tîme. 
Outputs 
1) Field validation of:the pen-side diagnostic test
2) Enable rapid pen-side diagnosis and allow rapid irnplementation of control measures,
hopefully resulting inja reduction in animal losses 
5. Motecular cha�.acterîsation of isolates and large animal pathogenesis
studies 
Introduction 
Altho\lgh nota resear� project, fund.ing must be set aside for the molecular characterisation 
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of all rinderpest virus' isolatcs. This provides the only means of tracing the source of 
outbreaks and bas proved crucial in enhanciug our undeI$tanding of the epidemiology of the 
disease in East Afiica There is an immense amount of work involved_ particularly when the 
samples have to be cloned and many clones sequenced Funding is cu:rrently supplied by FAO 
for the basic diagnostic service but does not cover the more expensive techniques such as 
molecular characterisation. Further funding i.s required. to provide a full-time dedicated 
service for PARC. 1 
Funding is also required for animal experimentation. This is particularly important when 
exaroioiog 'cmild', strains or strains isolated :from gam.e Mùnals, to determine tb.cir virulence 
in cattle. Particularly isolates giving a similar nucleotide sequence to the vaccine virus strain. 
Until nowthe pathogenicity studies carried out atPirbright have been atthe Institute's 
expense. It is propcseèl. tha.t a sum of money should be set a.sicle at the PARC Co-ordination 
Unit, Nairobi to coveT' animal experimentation costs as and when deemed necessary. The
selection of stralns and design of experiments wou.l.d be by ntutual consent between PARC 
and Ltùt as new outbr:eaks occurred or when strains are isolated. Funds would be àisbursed to 
IAB'. to cover the animal costs on completion of a suitable report. 
Ail these activities should be based at the WRLR and it would be higbly appropriate if they 
were undertaken in the fonn of a Fellowship by a. scientist from. one of the countrles involved 
in the PARC. The R�� Fellow would also carry out the above research projects witbin 
the two year period under the �ervision of staff' at the IAH Pirbright This would serve
almost as an apprenti�ship and would be ideal training for a scientist ultimat:ely to be 
. . responsible for a Re�onal Reference Labo.ratozy. This could be operated as a revolving �st 
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with the post holder replaced bieooiaUy, ensuring a coilStant updatlng of relevant staff. 
Ou.t.puts 
I) Fast, sustainable service for the molecular cbaracterisation of rinderpest virus ïsola:tes.
2) Better understandin� of the epidemiology of rindell)eSt in Africa.
3) Incre�ed understanding of the virulence of contempora1y virus isolates.
4) Regular, updating and b'aining of African scientists and creatfon of a pool of knowledge as
a sustainable resource for the future. 
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I. Costings for animal experimen'ls
a. Serial passage of mild strain in cattle, sbeep aud goat:i
24 cattle at :f.500 each: f �000 
Cattlc accommodation charges (BOO per month): 
li sheep (!70 each) 
12 goats (f..70 each) 
Sheep/goat acçommodation (flOO per month) 
b. Contact �nsmission experiments
15 cattle at :E.500 each: 







c. Detection of vaccine virus genome in eye swabs by PCR !ollowing vaccination
10 cattle at :E5UO ea.ch: 
Cattle accommodation charges (:ESOO per month) 
Total: 
2. Costs for fiddÎl'alidation of pen-side test
Approximate airfares x 'l. (Veterinarian and Soienµ$t): 
Pcr- diem for :Z ""',eeb: Veterlrmri:m· 
-· ··· ., .. ·· · Scientist: 













3. Cost5..for.. EU-PJRC Fellawship (an.nua!).
(Ideally the saiary and airfares would be paid direcily to the Research f'ellow): 
Researeh Fellëw sala1y (approx): f26,400 
N=onal ÎD.5m,mce/.sü.pertmnuZ!:tion J:G.336 
Airfare (apJtox): fl,500 
( dependant 01!- nationality of scientist) 
Consumables: 
(standard IAH annual bench fee) 











Now that RP is on the verge of eradication in Africa. CBPP is becoming lhe greatest threàt to catue 
caising. 
The reasons for this predicted aod seemiogly unavoidable re-emergence are numerous. For many 
y�i-s. the vaccir.ation campaigns against rindecpest had also cootributed to the fight against CBPP 
as combïned vaccines were used. Repe2ted v2ccinations raised the immunity of the cattle 
popo!ations significrntly and CBPP was under contrai vi.i.h (e-w sporadic out.breaks. Still now, 
countries that do vaccinate against CBPP on a regular basis. \'.'hatever the vaccine used. do no1. 
suffer from many out.breaks. These outbreaks are very often caused by importation of sick animais 
(rom neighboring countries. 
The abandon of mass vaccination against rinderpest will êiutomaticaHy ïnduce a drop in the 
immune status against C8PP and favour dissemïnation of the disease_ This is what happened 
in the horn of Africa ïn 1994-199S witn the re-e.stab(ishment of CBPP in countries such as 
Kenya, Tanzania and Uganda, which had been CBPP-fr� for many years_ 
Sporadic vaccination campaigns against CSPP are c.ot likely ta induce 2 significant drop in the 
prevalenœ of the disease. 
The oest pmphylactic 2pproach for disease-free and infeC<ed areas should continue to be that of 
targe scale and repeated vaccination. Good dïagnosis tools need also to be availab!e. 
However, the currentfy used attenuated live vaccines surfer from some limitations: short-terrn 
protection (at bcst vaccinated animais will be protected for one year),. not al! the animal are 
protected, use of live material. · ·with problems of Sï2bility of the strain, no vaccinal 
mar'f..er ... Furtherrnore. even if the qualriy CQntrol h2s œe:i improved by the establishment of 
PANVAC. on!y ô limited number of batches are controlled 2r.d vaccination failures can then also be 
due to other factors including bad rr.a!lufacturing p;-ocess. i:.1;:iroper stor2ge and mishandling by the 
v.3ccinators. 
Comp2rafr;.rely. recen! rese2rch has dram2tie2lly irriproved the diagnostic procedures. Direct 
de,edion by the Polymer2se Chain Reaction (PCR) nov, 2lio,·.-s 2 specific and rapid identification of 
the CBPP agent. This technique has the 2dvant2ge th2t i, could be used on dried samples (i.e. 
loaded on paper filter) sent to regiona! reference œnter v.ithout the need of a cold chain. New 
serological tests, 2s the competitive ELISA were developed 2nd sllould a!so pennit to establish a 
reliable evalu2tion of the disease prevalence. Furthermore. molecu!ar techniques also al!ow now the 
differenciation of strains coming from various regions. 
Therefore. in order to achieve the eradication of CBPP. the major tool which is sti!I missing is a good 
vaccine. For this purpose, the main goals whidl should be pursued are: ail vaccinated animais 
should be protected, impcovement of the duration of protection. it should last at least 2 years and 
improvement of the thermostabi!ity (vaccine efficacy shou!d less depend on the cold chain). 
Many appmaches can be checi<ed to develop new CBPP vaccine. The use of inactivated preparation 
certainly merits attention as new adjwants, now availab!e, may offer a better antigenic presentation 
and a better orientation of the immune responses. The development of recombinant vaccines could 
be very useful. By selecting the appropriate vector and pfOtedive protein(s), these type of vaccines 
could overcome the problems encountered with the dassical ones, induding the thermostability. 
Furthennore, the recombinant vaccines allow the introduction. in their genome, of a vaccinal macl<ec 
However, whatever the approach setected, preliminary studies have to be devetoped since vaccine 
efficacy rely on the developmeot of a protective immune response and on the fong-fasting of this 
protection_ Therefore, in order to select the appropriate adjwant for an attenuated vaccine or the 
appropriate antigen(s) inducing the protective response, one must know before what characteriz.es a 
C8PP-protective response. The preliminary step wïH then be ta understand the immunopathological 
mechanïsms leading to a state of disease or immunity to CBPP :and to deftne what :aspects of the 
immune response are responsëbles for protection. which specific antigens confer proted.ive immunity 
and also the duration of this immunity_ 
lt is already known that whereas humoral immune responses ptay a major raie in proteclion against 
systemic infections, protection against mycoplasma diseases of the mucosal surface appear.. to be 
accomplished via complex local and œfl-mediated immune mechanisms. 
Therefore, cellular immune . responses of cattle facing CBPP have to be studied to identify the 
subpopulation of lymphocytes recruited during the infection and by which antigen and the cytokine 
released. Understanding the interaction between the multiple cells of the immune system and the role 
of regulatory factors produced by these cells will hetp to explain the immunopathology of the disease. 
A comparison of lymphocyte recruitmeot. antigen invotved. cytokines factors released between 
infeded, recovered and vaccinated animais wiU define the proteclive responses and the pathogenic 
ones. 
According to these results, it will be possible. among the wide variety of adjuvants, to select the one 
which he(p to recruit the appropriate subpopulation of lymphocytes 1eading to the developmerrt of a 
protective immune response. 
A long-lasting protection is based on the development of immunological memory which rely on the 
presence of pathogen-specific-rmemory cefls having a long lifespan. This immunotogical memory, is 
defined by the acquircd property of the immune system to respond more rapidly and more intensively 
to a second antigen stimulation. Therefore it is important, when selecting antigens to develop 
recombinant vaccines, to identify the ones which, not only induœd a proteclive immune response but 
also long lasting memory cells. The memory ceUs have then to be used to screen the various 
mycoplasma antigens obtained by protein fractionation, in order to identify those eliciting an immune 
response which last over a long period ·�fter the vaccination. 
Therefore. in order to develop new GBPP .yaccine, the study of the cell-mediated immunity is the first 
step. The second step, to construct reçombinant vaccine or subunit vaccine, will be the identification 
of the proteins involved in long-term protection, the selection of the genes coding for these proteins 
and their expression in appropriate vectocs. The next steps will correspond lo the selection of the 
right adjuvant and vaccinal marker and then to check the new CBPP vaccine efficacy in the field by 
performing challenge experiments. 
OUTCOMES OF THESE EXPERIMENTS 
• Study of the cellular immune .responses feading to disease or protection
identification of the subpopulation of lymphocytes recruited 
identification of the cytokines released 
study of the responsiveness of the memory ce lis to various 
mycoplasma antigens 
• Identification of antigen(s) involved in protection
• Seleclion and cionage of the gene(s) coding for this (these) antigen(s)
• Selection of the appropriate vector and construction of a genetic recombinant expressing the
protein(s) involved in protection
• Selection of the appropriate adjuvant
• Test. of the vaccine efficacy by performing immunisation and challenge in the field
CONTAGIOUS BOVINE PLEUROPNEUMONIA 
EUROPEAN UNION 
Five year plan 
Main objective 
Improvement of vaccines 
Identified sub-objectives 
Seting up of a technique enabling the identification of the curently used T l  vaccine 
Identification of genes coding for virulence factors 
Characterization· of the cellular immune response triggered after a vaccination or 
during the onset of the disease 
Identification of antigens eliciting a protective response 
Preliminary field trials with newly developped candidate vaccines 
Measurable parameters for the control of the implementation oftp.e project 
Sequencing: 250.000bp (representing 115th of the complete genome) 
Cellular immune response analyzed in 1000 samples 
Expression and purification of 10 major antigens 
Experimental CBPP repro�uction in a high security confinment: 2 times 6 animais 
Experimental vaccine trials in ·developping countries: 3 times 50 animais 
Year l 2 .... 4 5 Total :) 
Technician 17 17 34 34 102 
Consumable 50 50 35 35 35 205 
Travel 8 8 8 24 
Equipment 40 60 100 
Experiment animais 
High sec. Conf 15 15 30 
Dev.Country 30 30 30 90 
Coordination 5 5 5 5 5 25 
Sub Total 127 87 167 112 78 576 





CONTAGIOUS BOVINE PLEUROPNEUMONIA 
EUROPEAN UNION 
Five year plan 
Main objective 
Study of antibiotic treatment efficacy 
APPENDIX4
Although antibiotic treatment of CBPP cases is discouraged by most official policies of 
veterinary services, it is obvious that owners do treat their animais knowingly or not. In countries 
where CBPP is highly prevalent and where eradication cannot be reached rapidly, well monitored 
antibiotic treatments might play a role in di.creasing the infective presure thus diminishing the 
spread ofCBPP. These treatment will have to be chosen according to the expected efficiency in 
vitro but also according to their expected cost. 
Identified sub-objectives 
Clinical improvement of treated animais 
Evaluation of the impact of treatment on the number of chronic carriers 
Measurable parameters for the con�ol of the implementation of the project 
Number of animals used 
Follow up of infected control animais 
Isolations of M mycoides subsp· mycoides SC 
Finance 
Year 1 2 4 








Geo-epidemio/ogical groups have been depned (see table in NSES paragraph) dependent on: 
•!• the geographicaf position of the country with respect to residuaf outbreaks 
•!• the zones and major /arming systems; the wi/d/i/e 
•!• commercial exchanges (see map page 73)
The risk of Rinderpest can be determined /rom these groups (shown in map page 72) and a strategy 
can be developed. 
4.1.1 West A/rica 
An end to vaccination, imp/ementation of a NSES (3 years) and assessment of the OIE pathway: 
OIE pathway: "For a country to be able to decfare that it is provisional/y unaf/ected by Rinderpest, it 
must /u.Jfif the /ollowing conditions: 
•!• Absence of c/;nicaffy detectab/e disease /or at feast 2 years; 
•!• Existence of a veterinary service able to watch over changes in animal heafth in the country; 
•!• Conduction of surveys by this service in the presence of any c/inica/ sign suggestive of 
Rinderpest; 
•!• Presence o/ an efficient system o/ declaration bath /rom the pe/d towards the centra/ 
veterinary administration and /rom the latter to the OIE; 
•!• Existence of a refiab/e warning system /or the introduction o/ infection by means o/ borders 
contrais, quarantine measures, etc 
•!• Total end to vaccination against Rinderpest at the date o/ the declaration, this decision 
prstly being notijied in writing to OIE and to the bordering countries with mention of the 
date of end of vaccination." 
(OIE recommendation reprinted in June 1993. Former/y entit/ed: Report o/ the expert consultation on 
Rinderpest surveillance systems, Paris, 16-18 August 1989). 
End of the 
vaccinations
Provisional freedom
from "disease" Disease free Infection free
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4.1.2 Central A/rica 
Main zone of cordon sanitaire 
The cordon sanitaire must involve the three countries bordering the in/ected and unaf/ected zones, Chad, 
CAR and Sudan. ln the prst place, it is a question of protecting Central and West A/rica /rom 
reintroduction of Rinderpest /rom localized outbreaks for lineage 1 of the virus in the East and Southeast 
of Sudan. 
The /act that there has been no Rinderpest in Chad and CAR despite the situation in Sudan and the 
weak immunization rate in the cordon can be explained by: 
•!• Sudanese outbreaks situated in the south east of the country (right bank of the Nile) 
•!• Weak transverse movements (essentially north-south) 
•!• lnter-epizootic period: /rom 10 to 15 years but increased even by partial vaccination. The 
last outbreaks in West and Central A/rica date back to mid-1988. 
This cordon is depned in the prst place as a vaccination cordon that includes the activities of surveillance 
and active search /or the virus. 
The requirement of 70-80% of animais vaccinated in order to contrai in/ectious disease is challenged by 
many studies and is to be modijied depending on the in/ectious disease. For the morbil/ivirus it seems 
that the minimum rate required is 90% (studies of measles and Rinderpest.) 
The borders of the cordon must take into account: : 
•!• the migratory movements of the herd 
•!• the commercial f/ows 
•!• clearly identijied geographical limits, road and hydrographie networks 
•!• national parks which can be used as sentinels in Chad and CAR. 
Elaborated /rom these dif/erent points, the /ollowing maps (pages 79 and 80) shows the theoretical limits 
/or a cordon. It has an average /rontier extent of 150 km in addition to a buf/er zone of 150 km with 
respect to a vaccination cordon (cordon + buf/er = 300 km, average distance that can be covered by 
Rinderpest in 1 week assuming transverse movements.} 
The actual limits of the cordon, based on physical boundaries, will be depned in detail /or each country. 
We propose: 
0 Chad 
Characteristics: north-south animal movements; entry of animais by CAR and encounters with animais 
/rom Sudan (notably Tizi lake); commerce with Cameroon and Nigeria. 
We can depne: 
1. A sanitary/vaccinal cordon pxed on the route Abéché-Bahr 2,
2. A buf/er zone (route Ati-Mongo-Me/j;-Mounou) where the seropositive / vaccinated animais can be
detected.
3. A third zone outside the buf/er zone.
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O CAR 
Characteristics: Concentration of catt/e and major transits to the northeast of the country; important 
wi/d/;fe. 
1. Vaccination and cordon sanitaire /or the part bordering Chad and the northeast, bordering Sudan
(see map);
Sanitary cordon in the southest o/ CAR: /ittle or no catt/e however with increased passage in the
south (commerce) and the surveyed catt/e in the park of this region according to certain sources. The
reduction in the pressure of tsetse flies in this zone /inked to the reduction in wi/d/;fe density has
allowed /armers to penetrate this environment.
2. Buf!er zone, inc/uding notab/y the main catt/e production zone {Bambari-Bria.)
3. A third zone outside the buf!er zone.
For Chad and the CAR zones 2 and 3 will be the object o/ progressive installation of the OIE pathway 
based on: 
•:• clinica/ surveillance: 300 herds per zone ( = stratum) 
•:• serological surveillance: 10 to 57 sera per stock of 10 to 100 cattle /or a sum total o/ 300
stocks per stratum. 
The buf!er zone has an intermediate epidemio/ogical status. With an extent of 150 km, it is a non­
vaccinated zone (end of vaccination p/anned /or 1999 in the buf!er zone by PARC Chad) but within 
which animais that may have been vaccinated will pass through. This zone however needs to be def;ned 
administrative/y so that contro/s are rein/orced on the traditiona/ movements and commercial f/ow. 
0 Sudan 
For south Sudan, a proposa/ o/ redef;ning it epidemio/ogically and strategically in 4 north-south zones 
/or the southern part (see maps pages 79 and 80):
1. Vaccination and cordon sanitaire (zone C "Cordon") along the borders with Chad and CAR and
up to the Ni/e /or the southern part. This concerns the /ollowing pre/ectures (the f;rst two are easi/y
accessible):
•:• western Dar/our 
•:• southern Dar/our 
•:• western Barh El Ghazal 
•:• northern Barh E/ Ghaza/ 
•:• western Equatoria 
•:• Barh El Djebel 
•:• El Bouheirat 
•:• Ouarab 
•:• El Ouahda 
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2. Jnfected zone with a central interior part of triangle Wau - Ma/aka/ -Juba of uncertain status and
difficult to reach (zone D "Disease ''):
•!• eastern Bquatoria 
•!• ]onglei 
•!• Upper Nile 
•!• Blue Nife 
•!• South of western Kordofan 
•!• southern Kordofan (suspicion of Rinderpest in the Nouba mountains ?) 
3. Zone B "Buf/er": maximum vaccination coverage (zones accessible to PARC Khartoum), set up
of NSES.
•!• south of northern Dar/our 




•!• Kas sala 
4. Zone A: reduced farming. lntegration in a NSES (with came/ disease?):
•!• (north of northern Dar/our 
•!• {North) 
•!• Nile 
•!• · Red sea
The following activities to be carried out in the main cordon, Chad-CAR and zone C of Sudan: 
•!• massive and continued vaccination (use of the thermostable vaccine); that represents a total 
of 8-10 mil/ion catt/e (1 -1.5 mil/ion of which in Chad, 100,000-200,000 in CAR 
but with periods where the concentration of animais is greater; in particular in CAR with 
migration and commercial transit /rom Sudan and Chad); 
•!• serologica/ monitoring: by rigorous samp/ing as de/ined by PARC /or evaluation of 
vaccination. 
•!• active surveillance /or Rinderpest by mobile teams: 2 per country based on surveys 
(markets, water ho/es, rumors) and samp/ing in c/inica/ Rinderpest-like-diseases. 
•!• management and up-dating based on geographic data on animal movements inc/uding the 
meeting zones and watering places; management at Abéché (coordinator) / N'Djamena (to 
be de/ined); this in order to optimize the follow up, vaccination and emergency intervention 
plans (must integrate routes, veterinary centres etc). Missions are necessary (2 per year) 
in addition to training (1 leader in Chad, equivalent to AT base at Abéché); materia/ 
(computer, Mapln/o so/tware, F/uxour module, GPS) 
•:• at the /imits o/ the cordon: guards, NSES posts and communication systems. Bntry and 
exit contro/ o/ the cordon and between countries: use o/ international vaccination certi/icates. 
•:• quarantine zones allowing entering and exiting animais to be vaccinated 
•:• coordination between the 3 countries with regu/ar visits between Abéché (Chad), Nya/a 
(Sudan) and Birao (CAR) 
•:• dependence on the epidemio/ogica/ surveillance network that covers the who/e territory 
•!• /egis/ative arsenal to be elaborated (consultancy to be planned). 
4.1.3 East A/rica 
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Vaccination and setting up of the NSES 
Vaccination cover in Kenya and Uganda /or the years -1 and-2 
Are deftned: 
•:• sectoral cordon sanitaires: vaccination, serological monitoring and surveillance: 
1. Cordons around south Sudan
2. Cordons Uganda / Kenya and Kenya / Tanzania
•:• bufler zones: surveillance 
•:• unaflected zones: application of OIE pathway 
Each zone constitutes a stratum in which the OIE system can be applied (herd sentinels, serology). 
The following table specijies the schedule and the d;f/erent activities to be carried out within the d;f/erent 
cordons. 
Year I 1 II 1 III IV 1 V 
West Ethiopia 
North Kenya VACCINATION and DURATION OF THE SURVEILLANCE 
North U ganda 
IMPLEMENTATION OF NSES {Continuation of vaccination 
: depending on evolution in 
CDR / Sudan (?) South-Sudan} 
Sudan {Zone B) VACCINATION and SURVEILLANCE
U ganda / Kenya 
VACCINATION and DURATION OF THE SURVEILLANCE 
Kenya/ Tanzania IMPLEMENTATION OF NSES 
4.2. CONTAGIOUS BOVINE PLEUROPNEUMONIA 
The following map (map page 81) deftnes : 
1. The primary outbreaks (4) : High Guinea /Niger interior delta; around lake Chad;
Sudan/Ethiopia; Angola. These are de/ined zones.
2. Countries which declared CBPP in 1997.
3. The zone of extension of the disease and/or the infection (probable or conftrmed zone).
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It is recommended to base the CBPP control on : 
4.2.1. Primary outbreaks. 
•:• Vaccination during several years with an intensive vaccinal scheme during the /irst year (at 
0, 3 and 9 months), then once a year, on the same identif;ed animais. ln al/, the cattle 
population in the primary outbreaks is estimated at 20 millions, with about 10 millions /or 
the eastern region. 
•:• Serological evaluation o/ the diminution of prevalence in the primary outbreaks (c-ELISA, 
serology on animais vaccinated /or more than 6 months). Samp/e o/ about 3 x 5000 sera. 
Starting year 2. 
•:• Surveillance in the abattoirs and slaughter areas. 
4.2.2. Other regions 
•:• Vaccination in the other zones : should be adapted according to the local prevalence. 
•:• Prevalence is o/ten underestimated; in a f;rst time, it is recommended to make a serological 









•:• Analysis of animal movements (Cf specific chapter). 
•:• Epidemiosurveillance 
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5. 
CONCLUSION 
Although Rinderpest remains current in East A/rica and much technica/, /ogistic and po/itical 
di//iculty is encountered in the field, overa/1, the PARC is a success. The positive economic 
impact of health improvements on animal production leads the consultants to propose integrated 
technica/ and geographical strategies. The national systems of epidemio/ogica/ surveillance, 
"pivots" o/ the /uture program of contro/ of trans-boundary diseases in sub-Saharan A/rica are 
mobi/izing al/ the "/ivestock actors" around them. 
6. 
AKNOWLEDGEMENTS 
The consultants would /ike to thank Dr W Masiga, Director of OAU/JBAR-PARC and 
his team /or welcoming us and donating their time. We would also /ike to thank all the 




• Blajan L. & Boisseau ]., 1997. Mission d'évaluation du Centre Pana/ricain de Vaccins
Vétérinaires (P ANV AC).
• Crowther ].R., 1997. Rinderpest: at war with the disease of war. Science Progress (1997), 80 (1),
21-43.
• AEEMA, 1996. Épidémiologie et Santé Animale. N '29
• F.A.O., 1996. The World Without Rinderpest. FAO Animal Production and Health Paper.
N °129. Proceedings of the FAO Technical Consultation on the Global Rinderpest Eradication
Programme. Rome, Italy, 22-24 July 1996
• F.A.O., 1997. Prevention and control o/ transboundary diseases. FAO Animal Production and
Health Paper. N °133. Report o/ the FAO expert consultation on the emergency prevention system
(EMPRES) /or transboundary animal and plant pests and diseases (Livestock diseases
programme) including the blueprint /or global Rinderpest eradication. Rome, Italy, 22-24 july
1996
• O.I.E., 1996. Animal mycoplasmoses and control. Revue Scientifique et technique. Vol. 15, N °
4, December 1996.
• Rossiter P.B., 1997. The Current status o/ Rinderpest and its control in A/rica. ln 1 ph West and
Central A/rica Regional Meeting o/ OUA/IBAR-PARC. N'djamena, Chad, july 1997, 4 pp.
• Coetzer ].A. W., Thomson G.R., Tostin. R. C.,1994. ln/ectious diseases o/ livestock.2 volumes,
Ox/ord University Press.
• Rinderpest emergency preparedness planning - A manual to assist in preparation o/ National




1. GENERAL CONTEXT OF THE ASSIGNMENT
The overal/ aim of the PARC program {Pan-A/rican Rinderpest Campaign) is to improve the 
revenue achieved by A/rican producers in the sub-sector o/ stockbreeding. The attempts to reach 
this goal occur by stimulating production through eradication of Rinderpest, and by 
improvements in services rendered to /armers and by the coordination on a pan-A/rican scale 
of epizootic contrai. 
The assignment will consist of technica/ support /or the Coordination Unit o/ the PARC 
Program /rom the OAU/IBAR in Nairobi. The purpose is to he/p identi/y, then /ormulate an 
overall future program of intervention in relation to a /ourth phase o/ the program. Then with 
a view to finance /rom Regional /unds of the eighth Buropean Deve/opment Fund the 
assignment will be subject to the FED committee. 
The assignment will be conducted in close collaboration with the other support provided /or 
IBAR /or the preparation o/ the /uture program. The contracting party will ensure that the 
gathering o/ resu/ts /rom these supports is simp/ijied in order to provide IBAR the /aci/ity to 
elaborate a conso/idated proposai /or presentation to the /unds o/ the Buropean Commission. 
The assignment will be made up o/ two sections: one section ''ANIMAL HEALTH" and one 
section FINANCE AND ADMINISTRATION. 
2. OBJECTIVES AND EXECUTION METHODS OF THE ASSIGNMENT
2.1 ANIMAL HEALTH SECTION 
General aims 
Con/orming to the recommendations of Stockbreeding specialists in the member countries o/ 
the Buropean Union during their last meeting o/ 2-4 ]une 1997 in Brusse/s, the genera/ 
aims o/ the support ass1'gnment will be to: 
discuss and define with the Coordination Unit a global strategy o/ final eradication of 
Rinderpest in the continent, taking account of the current epidemio/ogica/ situation of the 
disease and the results obtained its contra/ since the creation of the PARC program 
/ormulate, in particular, the operationa/ recommendations concerning the actions to be taken: 
concerning contrai and eradication, strict/y speaking, in the zones where Rinderpest is still 
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endemic {East A/rica), taking into account the recent deve/opments of the disease; 
concerning contrai and surveillance in the zones making up the "cordon sanitaire" 
concerning epidemiologica/ surveillance and epidemiological vigilance in the zones where the 
disease seems to have been eradicated {West A/rica), with particular re/erence to the 
arrangements of the "OIE pathway of declaration of countries unalfected by Rinderpest"; 
evaluate, in addition, the appropriateness and the /easibi/ity of contrai programs against other 
major trans-boundary epizootics and propose possible intervention synergies with existing 
or proposed systems of surveillance, epidemio/ogica/ vigilance and coordination in the contra/ 
of Rinderpest. 
Specif;c tasks 
The assignment sets out in particular to: 
achieve a global assessment of on-going or p/anned actions at the leve/ of countries visited, in 
particular concerning the setting up and running of epidemio/ogica/ 
surveillance/epidemiological vigilance networks and the cordon sanitaire 
study the suitabi/ity of the actions actually initiated or proposed in the countries visited with 
respect to the objectives set out above and the standard recommended methods of O JE /or 
epidemio/ogical surveillance of Rinderpest (OIE, June 1993); 
evaluate the human resources and materials available /or intensification in the surveillance and 
contrai of Rinderpest in each country visited including the cordon sanitiare on one hand 
and the requirements /or potentia/ contrai of other major diseases on the other hand; to 
do this the consultants will assess the strength available /or intervention by: 
the national veterinary services 
the national and regional laboratories 
the abattoirs 
the private veterinarians 
the /armers' organizations 
the existing projects in the domain of animal health with mufti- and/or bilateral /unding {World 
Bank, PNUD European Union NGO inter state Cooperation) in particular concerning 
the existing epidemio/ogica/ surveillance networks; 
evaluate the need /or research projects expressed by the national leaders and by the coordination 
unit of the technica/ committee of PARC. 
study the possible links between the /uture national constituents of the PARC program and the 
projects relating to wi/d /auna ftnanced by the European Union in relation to dif/erent 
A/rican countries and to establish sub-regional classifications and types of intervention 
necessary in matters of eradication, contrai and /or surveillance of Rinderpest. This will be 
based on the existing documentation /rom O JE O UA/IBAR, the MD VIII and CIRAD­
EMVT in addition to visits and the consultants' own knowledge. 
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On these same bases, recommendations wi/J also be established on the possibi/ities of joint 
contro/ of major transboundary diseases /or ail the economical/y important animal species; this 
wi// also be taken into account apart /rom the large epizootics, the zoonosis and the spreading 
diseases; 
/;na//y, evaluate the various possibi/ities of externa/ contro/ that the coordination unit cou/d re/y 
on /or monitoring and evaluation both /or anti-Rinderpest vaccination campaigns and /or 
epidemio/ogical surveillance and epidemio/ogica/ vigilance. 
Expected results 
The expected outcome of the assignment wil/ notab/y be: 
strategic, materia/ and operational proposais concerning the aim of Rinderpest eradication based 
on the aptitudes o/ the "OIE pathway" and the epidemio/ogica/ surveillance and 
epidemio/ogical vigilance networks that already exist, or wi/J be created, in the countries 
visited; these proposais wi/J speci/y in particular; 
the roles and responsibi/ities of d;J/erent agents with respect to the existing or /uture structures 
of health de/ense 
the role o/ private veterinarians and the /armers' co-operatives in the national networks 
the contribution and the spec;/ic ro/e expected of the sections of Bpidemio/ogy, 
Communication, Socioeconomics and P ANV AC 
the possible operationa/ mode of cooperation with the externa/ structures working /or the 
same objective (FAO, re/erence laboratories, research units); 
a characterization of the hea/th situation in a given country justijying intervention of one of the 
types proposed above; and on the basis o/ /acts in the consultants possession, an attempt 
at classification /rom this characterization of member countries of OAU; 
the adoption of coherent approaches to contro/ o/ other major health constraints that have been 
identif;ed, CBPP being in the /ront row; the control measures /or this wi/J have to take 
advantage of synergy with the actions aimed at eradication of Rinderpest /rom the 
continent; 
according to this fast comp/ementary approach, and as much as is necessary, the assi'gnment 
wi/J propose a research section concerning, in particular, the diagnostic techniques, the 
epidemio/ogy and immuno-protection vis-à-vis the major epizootics such as Rinderpest, 
CBPP PPR and CCPP: this section wi/J give rise to a budgetary estimation and spec1pc 
schedu/e; 
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a proposai relating to epidemio/ogica/ information and its mode of transmission (type, timing, 
/orm) at the /eve/ of OAU/IBAR in order that this institution can adequate/y play its role 
of coordination with respect to O IB standards. 
Methods of imp/ementing the assignment 
From a practica/ point of view, two pre/iminary consultation meetings are p/anned: 
one in Brusse/s with the leaders concerned with the MD VIII and the team charged with the 
formulation of the proposed PARC IV project; 
the other at Nairobi with the leaders of the coordination unit o/ PARC at OAU/IBAR. 
Among other things, these meetings wi// be the chance to decide f;na//y on the /ist of countries 
to visit; 
the visits in a certain number of sub-Saharan A/rica countries concerned by the PARC 
program: 
not wishing to inter/ere with the search /or information that the consultants may consider 
essentia/ /or their tasks, one cou/d however envisage inc/uding amongst the countn·es to visit 
particular/y: 
in the endemic zone: Kenya, Tanzania, Uganda ... 
in the zone to consider as the cordon sanitiare: Cameron, Rwanda ... ;
in the zone where it is recommended to cease anti-Rinderpest vaccination: Niger, Mauritania 
/or the Sahe/ian countries; Benin, Côte d'Ivoire /or the coasta/ countries; to establish eventua/ 
coordination with the countries of the SADC and other Regiona/ Organizations; 
ln addition, the preliminary consultation meetings will be an opportunity to establish the 
situation in Nigeria and Sudan within the /ramework o/ this assignment, in discussion with 
the leaders of OAU/IBAR and the Buropean Union. 
One meeting of restoration to OAU/JBAR in Nairobi to unite the team charged with the 
formulation of the PARC IV project and transmit a preliminary MEMO; 
The discussion of a PRELIMINARY REPORT which must be transmitted be/ore the end of 
November 1997 at the latest. 
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2.2 ADMINISTRATIVE AND FINANCIAL SECTION 
Main objectives 
Dun·ng the overal/ evaluation of the PARC program carried out in Ju/y 1996 (Cf ''Assignment 
of overa/J evaluation of the pan-A/rican campaign against Rinderpest" Def;nitive report March 
1997), diverse problems related to the administrative and f;nancia/ management of the program 
became evident. This was at the level of both the Buropean Commission headquarters and its 
representatives in the countries and at the leve/ of OAU/IBAR. 
However, f;nanci'a/ implementation of dif/erent successive projects and commitments requires 
additiona/ administrative approaches, notably concerning closure of commitments in order to 
cancel certain elements and release the balance of /unds availab/e. 
With re/erence to the assessments carried out and the recommendations formulated on the 
occasion of the aforementioned evaluation, the assignment wi// have two main objectives: 
together with services in charge of implementing the PARC program and the Commission, 
seeing to permanent up-dating of f;nancia/ performance indicators drawn up on this 
occasion, closure of commitments and release of the balance of /unds on the projects 
successive/y implemented up to now; 
prepare a /ramework of administrative and f;nancia/ evaluation of the program with a view to 
a possible fourth phase in the /uture that wi// permit assessment at the feve/ of both the 
Commission and the Coordination Unit based at the OAU/IBAR in Nairobi. 
Execution methods of the assignment 
The assignment wi/1 be comp/eted in two· phases: 
First, a f;nancia/ specia/ist in collaboration with the services of the commission wi// have the task 
of 
up-dating the data on the f;nancia/ engagements refated to the program 
ensuring the identijication, initiation and assessment of procedures of closure of engagements 
as far as possible: the specia/ist wi// (if necessary and on/y with the prior agreement of the 
MD VIIJ/G/3, with visits /rom them) provide his support to.this ef/ect to the Commission 
representatives in the country. 
With the appropriate services of the PARC program at OAU/IBAR and the BC 
representatives at Nairobi they wi// carry out the assessment: 
to evaluate the needs and the capacities of a decentralized administrative and f;nancia/ 
assessment which provides both the program leaders and the Representatives with a c/ear 
picture of changes during the end of the current /unding and the p/anned intermediate 
phase of 24 months; 
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carry out to this e/fect the essentia/ work of conception and setting up of performance indicators 
and training of personnel. 
This /;rst stage of activities wi// result in a PRELIMINARY REPORT submitted three 
months /rom the start of the assignment. In particular, it wi// be estab/ished what support is 
desirab/e at the /eve/ of the country as well as a classiftcation of this in /unction of the criteria 
o/ urgency and costs concerned. 
Second/y, the specialist wi/J have to propose a management plan and /;nancia/ overview /or a 
possible /ourth phase of the program to the Coordination Unit of the program and the services 
of the Commission. To this e/fect, the specia/ist will be involved more speci/;ca//y with; 
considering the recommendations of the /;nancia/ appendix of the report /or the a/orementioned 
overall evaluation; 
de/;ning the requirements /or information and the way to render it continuai/y accessible at the 
di/ferent levels where it is required; 
evaluate precise costs and /unding of this assessment; 
recommend an implementation procedure /or this assessment and specify the decision levels and 
processes that are involved; 
describe the posts and pro/iles of personne/ needed /or this assessment: as /ar as possible at this 
f eve/ the specia/ist wi/J pn'oritize the training o/ on-site managers with respect to recruitment 
of new collaborators, and if necessary specify the /urther training desirab/e; 
propose a timetable /or implementation of management. 
An INTERM.EDIATE REPORT on this work wil/ be submitted 6 months /rom the start of 
the assignment. Three months a/ter the transmission o/ this intermediate report, the specia/ist 
wi/J establish a DEFINITIVE REPORT depending on the remarks o/ OAU/IBAR and the 
services of the MD VIII. This report will contain in particular the /;na/ proposais concerning 
the assessment /ramework as we// as a current version of the /;nancia/ situation of the program. 
NB. The MD VIII wi// provide the /;nancia/ specialist with access to the necessary accounting 
data and in particular to the appropriate parts of the computing system. The necessary 
possibi/ities of international communication /or the assignment wi/J also be provided. Final/y, 
he/she will see to appropriate requests /rom Buropean Commission representatives in the 
country and its services as we// as the responsible authority of PARC. 
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3. SKILLS REQUIRED
The assignment wi// be carried out by a team composed of 
Two specia/ists in epidemio/ogy and tropical animal patho/ogy /or the ANIMAL HEALTH 
SECTION; one wi/J be in charge of conducting the work in west and centra/ A/rica, the other 
/or the countries of east A/rica. 
One /inancial specialist /or the ADMINISTRATIVE AND FINANCIAL SECTION. 
Al/ of the work wi// be carried out in collaboration and permanent consultation with the leaders 
of the coordination unit in Nairobi and the team in charge of /ormulating the PARC project. 
In particular, the schedules /or execution of activities and the supp/y of solicited reports /or each 
o/ the sections wi// be coordinated, as close/y as possible, with the team in charge of /ormulating 
the PARC N project. The due date /ixed /or the presentation of this to the committee of FED 
(June 1998) wi/J be taken into account. 
The estimation of the duration of the dif/erent p/anned interventions, and al/ the work required 
/or the realization of the present assignment concerning each of the two sections, wi// be carried 
out by the specialists on the basis of the general description /ormulated above and wi// be 
supp/ied in their initial proposa/. 
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